JP2014144920A - External composition for skin - Google Patents
External composition for skin Download PDFInfo
- Publication number
- JP2014144920A JP2014144920A JP2013012666A JP2013012666A JP2014144920A JP 2014144920 A JP2014144920 A JP 2014144920A JP 2013012666 A JP2013012666 A JP 2013012666A JP 2013012666 A JP2013012666 A JP 2013012666A JP 2014144920 A JP2014144920 A JP 2014144920A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- skin
- fermentation
- enzyme
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 74
- 239000000284 extract Substances 0.000 claims abstract description 65
- 240000007594 Oryza sativa Species 0.000 claims abstract description 45
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 45
- 235000009566 rice Nutrition 0.000 claims abstract description 43
- 239000000047 product Substances 0.000 claims abstract description 38
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 37
- 239000004310 lactic acid Substances 0.000 claims abstract description 37
- 241000894006 Bacteria Species 0.000 claims abstract description 35
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 24
- 239000007857 degradation product Substances 0.000 claims abstract description 20
- 235000006463 Brassica alba Nutrition 0.000 claims abstract description 4
- 238000011282 treatment Methods 0.000 claims description 33
- 102000035195 Peptidases Human genes 0.000 claims description 26
- 108091005804 Peptidases Proteins 0.000 claims description 26
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 16
- 229910000077 silane Inorganic materials 0.000 claims description 16
- 230000007515 enzymatic degradation Effects 0.000 claims description 13
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims description 10
- 241000196324 Embryophyta Species 0.000 claims description 9
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 8
- 244000060011 Cocos nucifera Species 0.000 claims description 8
- 241001313857 Bletilla striata Species 0.000 claims description 2
- 241000219193 Brassicaceae Species 0.000 claims description 2
- 244000128879 sarson Species 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 abstract description 69
- 108090000790 Enzymes Proteins 0.000 abstract description 68
- 238000000855 fermentation Methods 0.000 abstract description 65
- 230000004151 fermentation Effects 0.000 abstract description 65
- 240000002853 Nelumbo nucifera Species 0.000 abstract description 19
- 230000003712 anti-aging effect Effects 0.000 abstract description 8
- 230000002087 whitening effect Effects 0.000 abstract description 6
- 241000219198 Brassica Species 0.000 abstract description 5
- 206010014970 Ephelides Diseases 0.000 abstract description 5
- 208000003351 Melanosis Diseases 0.000 abstract description 5
- 239000003513 alkali Substances 0.000 abstract description 5
- 238000012545 processing Methods 0.000 abstract description 5
- 230000037303 wrinkles Effects 0.000 abstract description 3
- 235000011331 Brassica Nutrition 0.000 abstract description 2
- 230000006872 improvement Effects 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 241001313855 Bletilla Species 0.000 abstract 2
- 230000017854 proteolysis Effects 0.000 abstract 2
- 244000031988 Brassica alba Species 0.000 abstract 1
- 244000140786 Brassica hirta Species 0.000 abstract 1
- 235000011371 Brassica hirta Nutrition 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 239000005445 natural material Substances 0.000 abstract 1
- 238000007665 sagging Methods 0.000 abstract 1
- 238000010186 staining Methods 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 65
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 45
- -1 potassium hydroxide Chemical compound 0.000 description 40
- 210000003491 skin Anatomy 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 35
- 238000000605 extraction Methods 0.000 description 32
- 238000004519 manufacturing process Methods 0.000 description 32
- 239000002904 solvent Substances 0.000 description 31
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 23
- 235000019441 ethanol Nutrition 0.000 description 23
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 22
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 21
- 238000000034 method Methods 0.000 description 20
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 19
- 239000004365 Protease Substances 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 235000019834 papain Nutrition 0.000 description 18
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 16
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 15
- 239000012488 sample solution Substances 0.000 description 15
- 239000000725 suspension Substances 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 239000000843 powder Substances 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 239000002609 medium Substances 0.000 description 13
- 239000012046 mixed solvent Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 230000002401 inhibitory effect Effects 0.000 description 12
- 239000008213 purified water Substances 0.000 description 12
- 230000001954 sterilising effect Effects 0.000 description 12
- 240000005979 Hordeum vulgare Species 0.000 description 11
- 235000007340 Hordeum vulgare Nutrition 0.000 description 11
- 150000001298 alcohols Chemical class 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 11
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 11
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 11
- 229960004705 kojic acid Drugs 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 108090000526 Papain Proteins 0.000 description 10
- 238000002156 mixing Methods 0.000 description 10
- 229940055729 papain Drugs 0.000 description 10
- 238000004659 sterilization and disinfection Methods 0.000 description 10
- 229940058015 1,3-butylene glycol Drugs 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- 235000019437 butane-1,3-diol Nutrition 0.000 description 9
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 9
- 239000011259 mixed solution Substances 0.000 description 9
- 108010004032 Bromelains Proteins 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
- 235000019835 bromelain Nutrition 0.000 description 8
- 230000020411 cell activation Effects 0.000 description 8
- 229960002986 dinoprostone Drugs 0.000 description 8
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 230000008099 melanin synthesis Effects 0.000 description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 8
- 235000019833 protease Nutrition 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 108090001069 Chymopapain Proteins 0.000 description 7
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 7
- 229960002976 chymopapain Drugs 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 7
- 210000001339 epidermal cell Anatomy 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 235000013772 propylene glycol Nutrition 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 6
- 102100022624 Glucoamylase Human genes 0.000 description 6
- 108010059820 Polygalacturonase Proteins 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 241000235017 Zygosaccharomyces Species 0.000 description 6
- 229960005070 ascorbic acid Drugs 0.000 description 6
- 229940105039 coconut extract Drugs 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 244000274847 Betula papyrifera Species 0.000 description 5
- 235000009113 Betula papyrifera Nutrition 0.000 description 5
- 235000009109 Betula pendula Nutrition 0.000 description 5
- 235000010928 Betula populifolia Nutrition 0.000 description 5
- 235000002992 Betula pubescens Nutrition 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 241000194033 Enterococcus Species 0.000 description 5
- 241000233855 Orchidaceae Species 0.000 description 5
- 235000002597 Solanum melongena Nutrition 0.000 description 5
- 244000061458 Solanum melongena Species 0.000 description 5
- 108090000631 Trypsin Proteins 0.000 description 5
- 102000004142 Trypsin Human genes 0.000 description 5
- 239000007844 bleaching agent Substances 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 230000000593 degrading effect Effects 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000001814 pectin Substances 0.000 description 5
- 235000010987 pectin Nutrition 0.000 description 5
- 229920001277 pectin Polymers 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000009759 skin aging Effects 0.000 description 5
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 5
- 229960000401 tranexamic acid Drugs 0.000 description 5
- 239000012588 trypsin Substances 0.000 description 5
- 102000004400 Aminopeptidases Human genes 0.000 description 4
- 108090000915 Aminopeptidases Proteins 0.000 description 4
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 4
- 102000005367 Carboxypeptidases Human genes 0.000 description 4
- 108010006303 Carboxypeptidases Proteins 0.000 description 4
- 108010059892 Cellulase Proteins 0.000 description 4
- 108090000317 Chymotrypsin Proteins 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 108010008488 Glycylglycine Proteins 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 102000057297 Pepsin A Human genes 0.000 description 4
- 108090000284 Pepsin A Proteins 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 229940106157 cellulase Drugs 0.000 description 4
- 229960002376 chymotrypsin Drugs 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229940043257 glycylglycine Drugs 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 4
- 108020004410 pectinesterase Proteins 0.000 description 4
- 229940111202 pepsin Drugs 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N (9e,12z)-octadeca-9,12-dienoic acid Chemical compound CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- OYAQUBKYAKSHOA-UHFFFAOYSA-N 2-(2-hydroxy-5-propylphenyl)-4-propylphenol Chemical compound CCCC1=CC=C(O)C(C=2C(=CC=C(CCC)C=2)O)=C1 OYAQUBKYAKSHOA-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 3
- 240000006024 Lactobacillus plantarum Species 0.000 description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 3
- 241000194036 Lactococcus Species 0.000 description 3
- 241000192132 Leuconostoc Species 0.000 description 3
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 3
- 241001123227 Saccharomyces pastorianus Species 0.000 description 3
- 244000062793 Sorghum vulgare Species 0.000 description 3
- 241000235006 Torulaspora Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- 241000207194 Vagococcus Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 3
- 108090000637 alpha-Amylases Proteins 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000013592 cell lysate Substances 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 235000019713 millet Nutrition 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- 241000238876 Acari Species 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000193818 Atopobium Species 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 241001123652 Candida versatilis Species 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 241000206594 Carnobacterium Species 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 240000001929 Lactobacillus brevis Species 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 235000007189 Oryza longistaminata Nutrition 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 108010029182 Pectin lyase Proteins 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229940069521 aloe extract Drugs 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 108010019077 beta-Amylase Proteins 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000008278 cosmetic cream Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 108010002430 hemicellulase Proteins 0.000 description 2
- 229940059442 hemicellulase Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 239000010903 husk Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 108010062085 ligninase Proteins 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229940017219 methyl propionate Drugs 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical class O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- QVSVMNXRLWSNGS-UHFFFAOYSA-N (3-fluorophenyl)methanamine Chemical compound NCC1=CC=CC(F)=C1 QVSVMNXRLWSNGS-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- LNJRMYPOKFOJBQ-UHFFFAOYSA-N 1-(4-tert-butyl-4-methoxycyclohexa-1,5-dien-1-yl)ethanone Chemical compound COC1(C(C)(C)C)CC=C(C(C)=O)C=C1 LNJRMYPOKFOJBQ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- ATWGXJGRRXIETI-UHFFFAOYSA-N 2,5-diacetyloxybenzoic acid Chemical compound CC(=O)OC1=CC=C(OC(C)=O)C(C(O)=O)=C1 ATWGXJGRRXIETI-UHFFFAOYSA-N 0.000 description 1
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical class OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- GWHXAZLLZVWMNI-UHFFFAOYSA-N 2-acetyloxy-5-hydroxybenzoic acid Chemical compound CC(=O)OC1=CC=C(O)C=C1C(O)=O GWHXAZLLZVWMNI-UHFFFAOYSA-N 0.000 description 1
- UPHOTCBFZHQJEK-UHFFFAOYSA-N 2-hydroxy-5-propanoyloxybenzoic acid Chemical compound CCC(=O)OC1=CC=C(O)C(C(O)=O)=C1 UPHOTCBFZHQJEK-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 1
- GXNGGBMNYUHZOZ-UHFFFAOYSA-N 4-(1-hydroxybutyl)phenol Chemical compound CCCC(O)C1=CC=C(O)C=C1 GXNGGBMNYUHZOZ-UHFFFAOYSA-N 0.000 description 1
- NYARJMRXCRSQPJ-UHFFFAOYSA-N 4-(3-methylbutyl)benzene-1,3-diol Chemical compound CC(C)CCC1=CC=C(O)C=C1O NYARJMRXCRSQPJ-UHFFFAOYSA-N 0.000 description 1
- KTXUGZHJVRHQGP-UHFFFAOYSA-N 4-Hydroxy-1-(3-pyridinyl)-1-butanone Chemical compound OCCCC(=O)C1=CC=CN=C1 KTXUGZHJVRHQGP-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- 101710130006 Beta-glucanase Proteins 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 241001530515 Candida sake Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- 241000206593 Carnobacterium divergens Species 0.000 description 1
- 241000206600 Carnobacterium maltaromaticum Species 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 108010001817 Endo-1,4-beta Xylanases Proteins 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 241000282816 Giraffa camelopardalis Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010028688 Isoamylase Proteins 0.000 description 1
- 244000285963 Kluyveromyces fragilis Species 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 241000194038 Lactococcus plantarum Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001468192 Leuconostoc citreum Species 0.000 description 1
- 241001072282 Limnanthes Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 1
- 229930182636 Magnolignan Natural products 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 244000265736 Nelumbo pentapetala Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000012110 Pandanus odorus Nutrition 0.000 description 1
- 244000180021 Pandanus odorus Species 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000500340 Pediococcus damnosus Species 0.000 description 1
- 241000191996 Pediococcus pentosaceus Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 241000877399 Saccharomyces chevalieri Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241000207192 Vagococcus salmoninarum Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000186675 Weissella confusa Species 0.000 description 1
- 241000186837 Weissella kandleri Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241001247821 Ziziphus Species 0.000 description 1
- 235000001329 Ziziphus joazeiro Nutrition 0.000 description 1
- 244000158786 Ziziphus joazeiro Species 0.000 description 1
- 241000235033 Zygosaccharomyces rouxii Species 0.000 description 1
- QJWAAZMYZHWQPN-OHHBKISYSA-N [(2s)-2-[(2r)-3,4-di(dodecanoyloxy)-5-oxo-2h-furan-2-yl]-2-dodecanoyloxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@H](OC(=O)CCCCCCCCCCC)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCC)=C1OC(=O)CCCCCCCCCCC QJWAAZMYZHWQPN-OHHBKISYSA-N 0.000 description 1
- 241000192393 [Candida] etchellsii Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 108010045649 agarase Proteins 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 description 1
- 108010030291 alpha-Galactosidase Proteins 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 229940033280 alpha-arbutin Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000020054 awamori Nutrition 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 108010089807 chitosanase Proteins 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical class [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- SUSRLLXAXAIZPH-OBPIAQAESA-N hydroquinone beta-D-glucopyranoside Natural products OC[C@H]1O[C@@H](Cc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O SUSRLLXAXAIZPH-OBPIAQAESA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 108010090785 inulinase Proteins 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical group CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000015141 kefir Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940083256 peripheral vasodilators nicotinic acid and derivative Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- YRJKYHIIYRGTCC-UHFFFAOYSA-M potassium;2-hydroxy-4-methoxybenzoate Chemical compound [K+].COC1=CC=C(C([O-])=O)C(O)=C1 YRJKYHIIYRGTCC-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003166 prostaglandin E2 derivatives Chemical class 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- LRUISGPJGHTCRR-LEJBHHMKSA-M sodium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] sulfate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(OS([O-])(=O)=O)=C1O LRUISGPJGHTCRR-LEJBHHMKSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Abstract
Description
本発明は、すぐれた抗老化作用及び美白作用を有し、生体安全性の高い皮膚外用組成物に関するものである。 The present invention relates to an external composition for skin having excellent anti-aging action and whitening action and high biological safety.
皮膚の老化は、加齢に伴う細胞増殖・分化の不活化、ホルモン分泌の低下、細胞外マトリックス成分の量的低下などの内的要因と、太陽光(紫外線)、ハウスダスト、排気ガス、ダニなどによる細胞・組織の損傷、又は炎症などの外的要因とが複雑に絡み合って生ずる現象である。皮膚の老化の外的要因である紫外線は皮膚細胞に直接傷害を及ぼすばかりではなく、細胞外マトリックス成分のコラーゲンを変性又は架橋させてシワの形成や皮膚の弾力性の低下をもたらし、さらにはメラニン色素の異常沈着を誘発してシミ、ソバカスを生じさせるなど、肌に様々なダメージを与える。さらに、ハウスダスト、排気ガス、ダニなどは、皮膚の炎症やアレルギーを惹起する抗原となり、これにより、シミ、ソバカスなどが生じる。 Skin aging is caused by internal factors such as inactivation of cell growth / differentiation, hormonal secretion, and quantitative decrease of extracellular matrix components, and sunlight (ultraviolet rays), house dust, exhaust gas, mites. This is a phenomenon that is caused by complex intertwining of external factors such as cell / tissue damage due to the inflammation or inflammation. Ultraviolet rays, an external factor of skin aging, not only directly damages skin cells, but also denatures or cross-links the collagen of the extracellular matrix component to cause wrinkle formation and skin elasticity, and melanin It causes various damages to the skin, such as causing abnormal pigmentation and causing spots and freckles. Furthermore, house dust, exhaust gas, mites, and the like become antigens that cause skin inflammation and allergies, thereby causing spots, freckles, and the like.
以上の原因により生じる皮膚の老化を防ぎ、皮膚を健全、かつ、若々しい状態に保持するため、従来、種々の活性成分の使用が提案され、それら抗老化成分及び美白成分を配合した皮膚外用剤が上市されている。例えば、ビタミンC、ビタミンE、スーパーオキシドジスムターゼ(Superoxide dismutase;以下SODと略記)、カタラーゼなどの抗酸化剤;グリチルリチン酸、アラントインなどの抗炎症剤;各種紫外線吸収剤;α−ヒドロキシカルボン酸、胎盤抽出液、γ−アミノ−β−ヒドロキシ酪酸などの細胞賦活成分;コラーゲン、エラスチン、ヒアルロン酸などの細胞外マトリックス成分;尿素などの保湿剤がそれである。また、皮膚のシミ、ソバカス等の色素沈着の発生を抑制する物質としては、アルブチン、コウジ酸などが知られており、美白剤の有効成分として広く使用されている。 In order to prevent skin aging caused by the above causes, and to keep the skin healthy and youthful, the use of various active ingredients has been proposed in the past, and the topical use of these anti-aging ingredients and whitening ingredients The drug is on the market. For example, vitamin C, vitamin E, superoxide dismutase (hereinafter abbreviated as SOD), catalase and other antioxidants; glycyrrhizic acid, allantoin and other anti-inflammatory agents; various ultraviolet absorbers; α-hydroxycarboxylic acid, placenta Extracts, cell activation components such as γ-amino-β-hydroxybutyric acid; extracellular matrix components such as collagen, elastin and hyaluronic acid; and humectants such as urea. Further, arbutin, kojic acid, and the like are known as substances that suppress the occurrence of pigmentation such as skin spots and buckwheat, and are widely used as active ingredients of whitening agents.
しかし、それら従来の抗老化剤及び美白剤には、皮膚に対する安全性、また、実際に皮膚に適用した際の有効性の観点で問題が存在する。また、生体安全性を考慮して、種々の天然成分由来の抗老化剤及び美白剤も提案されているが(特許文献1、2)、それらの効果は、皮膚外用剤の配合原料として見た場合に、有効性の観点で十分に満足できるものとは言い難い。
本発明者らは、かかる従来技術の問題点に鑑みて、皮膚安全性に優れ、かつ、十分な有効性を発揮する天然物由来の新たな抗老化成分及び美白成分を見出すべく鋭意研究を行った。その結果、(a)米のアルカリ抽出物を2種以上の蛋白分解酵素で処理して得られた酵素分解物と、(b)アブラナ科ブラシカ属の白芥の種子(白芥子)の抽出物を蛋白分解酵素で処理して得られる酵素分解物と、(c)スイレン科ハス属の植物の種子を乳酸菌で発酵させて得られる発酵物と、(d)ハトムギの種子を酵母で発酵させて得られる発酵物と、(e)ラン科シラン属のシランの球根の抽出物と、を必須成分として含む皮膚外用組成物が安全性に優れ、かつ、低濃度で優れた抗老化効果及び美白効果を発揮することを見出して、本発明を完成させるに至った。 In view of the problems of the prior art, the present inventors have conducted intensive research to find new anti-aging components and whitening components derived from natural products that are excellent in skin safety and exhibit sufficient effectiveness. It was. As a result, (a) an enzyme degradation product obtained by treating an alkaline extract of rice with two or more types of proteolytic enzymes, and (b) an extract of white birch seeds (white coconut) of Brassicaceae (C) fermented product obtained by fermenting seeds of the genus Lotusaceae with lactic acid bacteria, and (d) fermenting barley seeds with yeast. The composition for external use containing the obtained fermented product and (e) a silane bulb extract of the Orchidaceae silane genus as an essential component is excellent in safety, and has excellent anti-aging effect and whitening effect at a low concentration As a result, the present invention has been completed.
本発明は、(a)米のアルカリ抽出物を2種以上の蛋白分解酵素で処理して得られた酵素分解物と、(b)アブラナ科ブラシカ属の白芥の種子(白芥子)の抽出物を蛋白分解酵素で処理して得られる酵素分解物と、(c)スイレン科ハス属の植物の種子を乳酸菌で発酵させて得られる発酵物と、(d)ハトムギの種子を酵母で発酵させて得られる発酵物と、(e)ラン科シラン属のシランの球根の抽出物と、を必須成分として含む皮膚外用組成物である。
また、本発明は、上記皮膚外用組成物を配合した化粧料である。
なお、本発明において、化粧料なる文言は、所謂医薬部外品を含む広義の意味で用いるものとする。
The present invention includes (a) an enzymatic degradation product obtained by treating an alkaline extract of rice with two or more types of proteolytic enzymes, and (b) an extraction of white birch seeds (white coconut) of Brassicaceae Brassica (C) a fermented product obtained by fermenting the seeds of the genus Lotusaceae with lactic acid bacteria, and (d) fermenting the seeds of pearl barley with yeast. A fermented product obtained in this manner, and (e) a silane bulb extract of the Orchidaceae silane genus, as an essential component.
Moreover, this invention is the cosmetics which mix | blended the said skin external composition.
In the present invention, the term cosmetic is used in a broad sense including so-called quasi drugs.
本発明は、(a)米のアルカリ抽出物を2種以上の蛋白分解酵素で処理して得られた酵素分解物と、(b)アブラナ科ブラシカ属の白芥の種子(白芥子)の抽出物を蛋白分解酵素で処理して得られる酵素分解物と、(c)スイレン科ハス属の植物の種子を乳酸菌で発酵させて得られる発酵物と、(d)ハトムギの種子を酵母で発酵させて得られる発酵物と、(e)ラン科シラン属のシランの球根の抽出物と、を必須成分として含む皮膚外用組成物であって、各成分が有する、様々な作用機序(表皮細胞賦活効果、抗炎症効果[プロスタグランジン生成抑制効果]、メラニン生成抑制効果)に基づく抗老化作用及び美白作用の相乗効果により、格段に優れたシワ、タルミ、シミ及びソバカスの予防、改善効果を発揮する。さらに、本発明によれば、多面的及び複合的な作用機序に基づいて、総合的に皮膚の老化現象を予防、改善することができることから、各成分の配合量を低濃度に抑えて、臭い、使用感、安定性及び安全性に優れた皮膚外用組成物を提供することもできる。 The present invention includes (a) an enzymatic degradation product obtained by treating an alkaline extract of rice with two or more types of proteolytic enzymes, and (b) an extraction of white birch seeds (white coconut) of Brassicaceae Brassica (C) a fermented product obtained by fermenting the seeds of the genus Lotusaceae with lactic acid bacteria, and (d) fermenting the seeds of pearl barley with yeast. And (e) an extract of silane bulbs belonging to the family Orchidaceae silane as essential components, each component having various action mechanisms (epidermal cell activation) Anti-aging effect and whitening action based on anti-inflammatory effect [prostaglandin production inhibitory effect], melanin production inhibitory effect), and exerts an excellent prevention and improvement effect on wrinkles, tarmi, stains and freckles To do. Furthermore, according to the present invention, the skin aging phenomenon can be comprehensively prevented and improved based on a multifaceted and complex action mechanism, so that the blending amount of each component is suppressed to a low concentration, It is also possible to provide an external composition for skin excellent in odor, feeling in use, stability and safety.
本発明は、(a)米のアルカリ抽出物を2種以上の蛋白分解酵素で処理して得られた酵素分解物と、(b)アブラナ科ブラシカ属の白芥の種子(白芥子)の抽出物を蛋白分解酵素で処理して得られる酵素分解物と、(c)スイレン科ハス属の植物の種子を乳酸菌で発酵させて得られる発酵物と、(d)ハトムギの種子を酵母で発酵させて得られる発酵物と、(e)ラン科シラン属のシランの球根の抽出物と、を必須成分として含む皮膚外用組成物である。 The present invention includes (a) an enzymatic degradation product obtained by treating an alkaline extract of rice with two or more types of proteolytic enzymes, and (b) an extraction of white birch seeds (white coconut) of Brassicaceae Brassica (C) a fermented product obtained by fermenting the seeds of the genus Lotusaceae with lactic acid bacteria, and (d) fermenting the seeds of pearl barley with yeast. A fermented product obtained in this manner, and (e) a silane bulb extract of the Orchidaceae silane genus, as an essential component.
(a)米のアルカリ抽出物の酵素分解物の調製
本発明に於いて用いる米には特に制限はなく、玄米、精白米、加工米、有色素米(黒米、紫米、赤米など)などのいずれもが使用可能であるが、好適には精白米もしくは加工米が使用される。米の種類としては、粳米、もち米等のいずれを使用してもよい。また、加工米としては、抗アレルギー米、低蛋白米(例えば低グリテリン米)、強化米(例えばγ−アミノ酪酸米)などが挙げられる。又、玄米に含まれる白糠及び/又は赤糠の使用も可能である。
(A) Preparation of enzymatic decomposition product of alkaline extract of rice No particular limitation is imposed on the rice used in the present invention, such as brown rice, polished rice, processed rice, pigmented rice (black rice, purple rice, red rice, etc.), etc. Any of these can be used, but preferably polished rice or processed rice is used. As the type of rice, either sticky rice or glutinous rice may be used. In addition, examples of processed rice include antiallergic rice, low protein rice (for example, low glycerin rice), and fortified rice (for example, γ-aminobutyric acid rice). Moreover, the use of white rice and / or red rice contained in brown rice is also possible.
米のアルカリ抽出処理で用いられる溶媒としては、例えば、精製水;エタノールなどの低級アルコール類;エチレングリコール、プロピレングリコール、グリセリン、1,3−ブチレングリコールなどの多価アルコール類;オレイルアルコール、ステアリルアルコール、オクチルドデカノールなどの高級アルコール類;アセトンなどのケトン類;酢酸エチルなどのエステル類;ヘキサン、クロロホルム、ベンゼンなどの炭化水素系溶剤などがあげられ、これらは単独もしくは2種以上を混合して用いられる。これらのうち、皮膚外用剤への幅広い適用という点で、精製水または精製水とエタノール、グリセリン、1,3−ブチレングリコールとの1種または2種以上を混合した溶媒が好ましい。これらの混合溶媒を用いる場合の容量比は、精製水とエタノールは1〜25:1、精製水とグリセリンは1〜15:1、精製水と1,3−ブチレングリコールは1〜15:1が好ましい。 Examples of the solvent used in the alkaline extraction treatment of rice include purified water; lower alcohols such as ethanol; polyhydric alcohols such as ethylene glycol, propylene glycol, glycerin and 1,3-butylene glycol; oleyl alcohol and stearyl alcohol. And higher alcohols such as octyldodecanol; ketones such as acetone; esters such as ethyl acetate; hydrocarbon solvents such as hexane, chloroform and benzene. These may be used alone or in combination of two or more. Used. Among these, the solvent which mixed 1 type, or 2 or more types of purified water or purified water, and ethanol, glycerol, and 1, 3- butylene glycol is preferable at the point of the wide application to a skin external preparation. When these mixed solvents are used, the volume ratio is 1 to 25: 1 for purified water and ethanol, 1 to 15: 1 for purified water and glycerol, and 1 to 15: 1 for purified water and 1,3-butylene glycol. preferable.
アルカリ抽出処理で用いられるアルカリ調製剤としては、例えば、水酸化ナトリウム、炭酸ナトリウムなどのナトリウム塩、水酸化カリウムなどのカリウム塩などがあげられ、これらのpHは7.5
〜14.0に設定される。これらのうち低濃度で目的のpHに設定できるため、水酸化ナトリウム、炭酸ナトリウムが好ましい。
Examples of the alkali preparation agent used in the alkali extraction treatment include sodium salts such as sodium hydroxide and sodium carbonate, potassium salts such as potassium hydroxide, and the like.
Set to ~ 14.0. Of these, sodium hydroxide and sodium carbonate are preferred because they can be set to the target pH at a low concentration.
アルカリ抽出処理時間は用いる溶媒やアルカリ調製剤の種類、設定pH、抽出温度などによって異なるが、pH8.5 〜14.0、室温で6時間〜7日間が好ましい。 The alkali extraction treatment time varies depending on the type of the solvent and alkali preparation used, the set pH, the extraction temperature, etc., but is preferably 8.5 to 14.0 and 6 hours to 7 days at room temperature.
以上のようにして調製した米のアルカリ抽出物を蛋白分解酵素により加水分解する。使用する酵素としては、例えば、アクチナーゼなどのアクチナーゼ類、ペプシンなどのペプシン類、トリプシン、キモトリプシンなどのトリプシン類、パパイン、キモパパインなどのパパイン類、グリシルグリシンペプチダーゼ、カルボキシペプチダーゼ、アミノペプチダーゼなどのペプチダーゼ類、ブロメライン、微生物由来の複合蛋白分解酵素[例えば、ニューラーゼ(天野エンザイム株式会社製)]などが挙げられ、これらの酵素の2種以上を組み合わせて使用することが好ましい。特に、パパイン類、ブロメライン及び/又はアクチナーゼ類を組み合わせて使用することが好ましい。 The alkaline extract of rice prepared as described above is hydrolyzed with a protease. Examples of the enzyme to be used include actinases such as actinase, pepsins such as pepsin, trypsins such as trypsin and chymotrypsin, papains such as papain and chymopapain, and peptidases such as glycylglycine peptidase, carboxypeptidase and aminopeptidase. , Bromelain, microbial-derived complex proteolytic enzymes [for example, neurase (manufactured by Amano Enzyme Co., Ltd.)] and the like, and it is preferable to use a combination of two or more of these enzymes. In particular, it is preferable to use a combination of papains, bromelain and / or actinases.
2種以上の酵素を組み合わせた処理は、用いる酵素の特性に応じて、2種以上の酵素を同時に作用させてもよく、又反応条件を変え、又は変えずして順次作用させるようにしてもよい。酵素の使用量は、米のアルカリ抽出物の固形分100重量部に対して、1種の酵素につき0.001〜50重量部の範囲とするのがよく、より好ましくは0.1〜10重量部の範囲である。又、酵素処理の時間及び温度は、用いる酵素の種類等によっても異なるが、一般には0.5〜24時間の範囲であり、好ましくは1〜6時間の範囲である。なお、酵素処理温度は一般には約30〜50℃である。 In the treatment of combining two or more enzymes, two or more enzymes may be allowed to act simultaneously depending on the properties of the enzyme used, or may be allowed to act sequentially with or without changing the reaction conditions. Good. The amount of the enzyme used is preferably in the range of 0.001 to 50 parts by weight, more preferably 0.1 to 10 parts by weight per one enzyme with respect to 100 parts by weight of the solid content of the alkaline extract of rice. Part range. The enzyme treatment time and temperature vary depending on the type of enzyme used, but are generally in the range of 0.5 to 24 hours, and preferably in the range of 1 to 6 hours. The enzyme treatment temperature is generally about 30 to 50 ° C.
上述のように調製した酵素分解物は、一般にはpHを4〜8に調製した上で、これをそのままの状態で皮膚外用組成物の一成分として使用しても良く、又減圧濃縮等により所望の濃度として使用しても良い。また、酵素分解物はスプレードライ法、凍結乾燥法等の常法により乾燥物としても良い。 The enzyme degradation product prepared as described above may be used as a component of a composition for external use of skin after adjusting the pH to 4 to 8, and may be used by concentrating under reduced pressure. You may use as a density | concentration. The enzyme degradation product may be a dried product by a conventional method such as a spray drying method or a freeze drying method.
(b)白芥の種子(白芥子)の酵素処理分解物の調製
本発明において使用する白芥子とは、アブラナ科ブラシカ属の植物である白芥(Brassica alba)の種子をいう。
(B) Preparation of enzyme-treated decomposition product of birch seed (white coconut) The white cocoon used in the present invention refers to the seed of Brassica alba which is a plant belonging to the genus Brassica.
本発明においては、白芥子の抽出物を酵素により加水分解する。抽出に用いる溶媒としては、水;メタノール、エタノール、プロパノールなどの低級アルコール類;エチレングリコール、プロピレングリコール、1、3−ブチレングリコール、グリセリンなどの多価アルコール類;酢酸エチル、酢酸ブチル、プロピオン酸メチルなどのエステル類;アセトン、メチルエチルケトンなどのケトン類;エチルエーテル、イソプロピルエーテルなどのエーテル類;n−ヘキサン、トルエン、クロロホルムなどの炭化水素系溶媒などが挙げられ、それらは単独でもしくは2種以上混合して用いられる。 In the present invention, a white coconut extract is hydrolyzed by an enzyme. Solvents used for extraction include water; lower alcohols such as methanol, ethanol, and propanol; polyhydric alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol, and glycerin; ethyl acetate, butyl acetate, and methyl propionate. Esters such as acetone; ketones such as acetone and methyl ethyl ketone; ethers such as ethyl ether and isopropyl ether; hydrocarbon solvents such as n-hexane, toluene and chloroform, and the like. These may be used alone or in combination of two or more. Used.
それら抽出溶媒のうちでも、得られる抽出物の皮膚生理活性の観点、さらには次工程の蛋白分解酵素処理への移行の容易さ及び該処理の効率等の観点から、水又は水と低級アルコール類或いは多価アルコール類などの親水性溶媒との混合溶媒の使用が好ましく、なかでも水の単独使用が最も好ましい。水と親水性溶媒との混合溶媒を用いる場合、その混合比は、例えば水とエタノールとの混合溶媒であれば、容量比(以下同じ)で100:1〜1:1、水と1,3−ブチレングリコールとの混合溶媒であれば、100:1〜1:2、又水とグリセリンとの混合溶媒であれば、100:1〜1:4の範囲とするのがよい。 Among these extraction solvents, water or water and lower alcohols are used from the viewpoint of skin physiological activity of the extract obtained, and also from the viewpoint of ease of transfer to the subsequent proteolytic enzyme treatment and the efficiency of the treatment. Alternatively, a mixed solvent with a hydrophilic solvent such as a polyhydric alcohol is preferably used, and water alone is most preferable. In the case of using a mixed solvent of water and a hydrophilic solvent, the mixing ratio is, for example, a mixed solvent of water and ethanol, with a volume ratio (hereinafter the same) of 100: 1 to 1: 1, water and 1,3. -If it is a mixed solvent with butylene glycol, it is good to set it as the range of 100: 1 to 1: 2 if it is a mixed solvent of water and glycerin.
抽出に際して、抽出液のpHに特に限定はないが、一般には3.0〜9.0の範囲とすることが好ましく、かかる意味で、必要ならば前記の抽出溶媒に、水酸化ナトリウム、炭酸ナトリウム、水酸化カリウムなどのアルカリ性調整剤や、クエン酸、塩酸、リン酸、硫酸などの酸性調整剤等を添加し、目的とするpHとなるように調整してもよい。 At the time of extraction, the pH of the extract is not particularly limited, but generally it is preferably in the range of 3.0 to 9.0. In this sense, if necessary, the extraction solvent may be sodium hydroxide, sodium carbonate. Alternatively, an alkaline adjusting agent such as potassium hydroxide or an acidic adjusting agent such as citric acid, hydrochloric acid, phosphoric acid or sulfuric acid may be added to adjust the pH to a desired level.
抽出温度、抽出時間等の抽出条件は、用いる溶媒の種類やpH、或いは被抽出物の細切度、粒度等によっても異なるが、例えば水を抽出溶媒とする浸漬法の場合であれば、抽出温度は一般に1〜90℃、好ましくは20〜60℃の範囲であり、又抽出時間は、室温抽出の場合で一般に0.5〜72時間の範囲、好ましくは1〜24時間の範囲である。 Extraction conditions such as extraction temperature and extraction time vary depending on the type and pH of the solvent used, or the shredding degree and particle size of the extract, but for example, in the case of the immersion method using water as the extraction solvent, extraction is performed. The temperature is generally in the range of 1 to 90 ° C., preferably 20 to 60 ° C., and the extraction time is generally in the range of 0.5 to 72 hours, preferably in the range of 1 to 24 hours in the case of room temperature extraction.
次に、ここに得られた抽出液を1種又は2種以上の蛋白分解酵素で処理し、抽出物に酵素分解処理を施す。この場合、抽出物溶液の調製に、水又は水と親水性溶媒との混合溶媒以外の溶媒を用いたときには、抽出物溶液から一旦抽出溶媒を除去し、ここに得られる抽出物を、水又は水と親水性溶媒との混合溶媒に再溶解した上酵素分解処理に供するようにする。 Next, the extract obtained here is treated with one or more proteolytic enzymes, and the extract is subjected to an enzymatic degradation treatment. In this case, when a solvent other than water or a mixed solvent of water and a hydrophilic solvent is used for the preparation of the extract solution, the extract solvent is once removed from the extract solution, and the extract obtained here is washed with water or The sample is redissolved in a mixed solvent of water and a hydrophilic solvent and then subjected to an enzymatic decomposition treatment.
蛋白分解酵素としては、例えばアクチナーゼなどのアクチナーゼ類、ペプシンなどのペプシン類、トリプシン、キモトリプシンなどのトリプシン類、パパイン、キモパパインなどのパパイン類、グリシルグリシンペプチダーゼ、カルボキシペプチダーゼ、アミノペプチダーゼなどのペプチダーゼ類、ブロメラインなどが挙げられ、それらはいずれか1種を単独で用いても或いは2種以上を組み合わせ用いてもよい。それら酵素のうちでも、アクチナーゼなどのアクチナーゼ類、パパイン、キモパパインなどのパパイン類又はブロメラインが特に好ましい。 Examples of proteolytic enzymes include actinases such as actinase, pepsins such as pepsin, trypsins such as trypsin and chymotrypsin, papains such as papain and chymopapain, peptidases such as glycylglycine peptidase, carboxypeptidase and aminopeptidase, Bromelain etc. are mentioned, and these may be used alone or in combination of two or more. Among these enzymes, actinases such as actinase, papains such as papain and chymopapain, and bromelain are particularly preferable.
蛋白分解酵素処理は、白芥子の抽出物に上記の酵素の1種又は2種以上を添加し、用いた酵素の至適pH及び至適温度付近の条件下で酵素反応させることで行う。2種以上の酵素を組み合わせ用いる場合は、用いる酵素の特性に応じて、2種以上の酵素を同時に作用させてもよく、又反応条件を変えもしくは変えずして順次作用させるようにしてもよい。酵素の使用量は、白芥子の抽出物の固形分100重量部に対して、1種の酵素につき0.001〜50重量部の範囲とするのがよく、より好ましくは0.1〜10重量部の範囲である。又、酵素処理の時間は、用いる酵素の種類等によっても異なるが、一般には0.5〜24時間の範囲であり、好ましくは1〜6時間の範囲である。なお、以上の蛋白分解酵素処理は、場合によってはその前工程である抽出処理の際それと同時に行ってもよい。 Proteolytic enzyme treatment is carried out by adding one or more of the above enzymes to the white coconut extract and carrying out an enzyme reaction under conditions near the optimum pH and temperature of the enzyme used. When two or more kinds of enzymes are used in combination, two or more kinds of enzymes may be allowed to act simultaneously according to the characteristics of the enzyme used, or may be allowed to act sequentially without changing or changing the reaction conditions. . The amount of the enzyme used should be in the range of 0.001 to 50 parts by weight, more preferably 0.1 to 10 parts by weight per one enzyme, based on 100 parts by weight of the solid content of the white coconut extract. Part range. The enzyme treatment time varies depending on the type of enzyme used and the like, but is generally in the range of 0.5 to 24 hours, preferably in the range of 1 to 6 hours. In addition, the proteolytic enzyme treatment described above may be performed simultaneously with the extraction treatment, which is the previous step, in some cases.
以上の蛋白分解酵素による処理が終了した後は、酵素処理液を例えば80℃以上に加熱する方法など適宜の方法を用いて酵素を失活させて、酵素分解物を得る。ここに得られる酵素分解物は、一般にはpHを4〜8に調整した上、これをそのまま皮膚外用組成物に配合するか、もしくは必要ならば減圧濃縮等により所定の濃度に調整した上で皮膚外用組成物に配合する。又場合によっては、スプレードライ法、凍結乾燥法など常法に従って粉末化してもよい。 After the above treatment with the proteolytic enzyme is completed, the enzyme is deactivated by using an appropriate method such as a method of heating the enzyme treatment solution to 80 ° C. or higher to obtain an enzyme degradation product. The enzyme degradation product obtained here is generally adjusted to a pH of 4 to 8 and then blended into the composition for external use as it is, or if necessary, adjusted to a predetermined concentration by vacuum concentration or the like, and then the skin. It mix | blends with an external composition. In some cases, the powder may be pulverized according to a conventional method such as spray drying or freeze drying.
(c)ハス種子の発酵物の調製
本発明で用いるスイレン科ハス属の植物としては、例えばハス(Nelumbo nucifera
Gaertner)或いはアメリカキバス(Nelumbo Lutea Pers.)などが挙げられるが、それらのうちでも、ハス(Nelumbo nucifera Gaertner)の使用が好ましい。
(C) Preparation of fermented lotus seed As a plant belonging to the genus Lotusaceae used in the present invention, for example, lotus (Nelumbo nucifera)
Gaertner) or American kibas (Nelumbo Lutea Pers.) Can be mentioned. Among them, the use of lotus (Nelumbo nucifera Gaertner) is preferable.
ハス種子の発酵に用いる微生物としては、乳酸菌から選ばれた1種又は2種以上を用いる。乳酸菌としては、例えばラクトバシルス プランタラム(Lactobacillus plantarum)、ラクトバシルス ブレビス(L.
brevis)、ラクトバシルス カゼイ(L. casei)等のラクトバシルス(Lactobacillus)属の乳酸菌;カルノバクテリウム ディバージェンス(Carnobacterium
divergens)、カルノバクテリウム ピシコーラ(Carnobacterium piscicola)等のカルノバクテリウム(Carnobacterium)属の乳酸菌;ロイコノストック メセンテロイズ(Leuconostoc
mesenteroides)、ロイコノストック シトレウム(Leuconostoc citreum)等のロイコノストック(Leuconostoc)属の乳酸菌; ストレプトコッカス フェーカリス(Streptococcus
faecalis)、ストレプトコッカス ピオジェネス(Streptococcus pyogenes)等のストレプトコッカス属の乳酸菌;エンテロコッカス
カゼリフラバス(Enterococcus caseliflavus)、エンテロコッカス サルフレウス(Enterococcus sulfreus)等のエンテロコッカス(
Enterococcus)属の乳酸菌;ラクトコッカス プランタラム(Lactococcus
plantarum) ラクトコッカス ラフィノラクティス(Lactococcus rafinolactis)等のラクトコッカス属の乳酸菌;ヴェイセラ
コンフューザ(Weissella confusa)、ヴェイセラ カンドウレリ(Weissella kandleri)等のヴェイセラ属の乳酸菌;アトポビウム ミニュタム(Atopobium minutum)、アトポビウム パービュラス(Atopobiumparvulus)等のアトポビウム(Atopobium)属の乳酸菌;バゴコッカス フルビアリス(Vagococcus
fluvialis)、バゴコッカス サーモニナラム(Vagococcus salmoninarum)等のバゴコッカス(Vagococcus)属の乳酸菌;ペディオコッカス ダムノサス(Pediococcus
damnosus)、ペディオコッカス ペントサセウス(Pediococcus pentosaceus)等のペディオコッカス(Pediococcus)属の乳酸菌等が挙げられる。それら乳酸菌のうちでも、得られる発酵物の皮膚生理活性の観点とさらに極端な嫌気性でなく取り扱い易いという点から、ラクトバシルス
プランタラム(Lactobacillus plantarum)の使用が最も好ましい。
As the microorganism used for the fermentation of the lotus seed, one kind or two or more kinds selected from lactic acid bacteria are used. Examples of lactic acid bacteria include Lactobacillus plantarum and Lactobacillus brevis (L.
brevis), Lactobacillus genus Lactobacillus, such as L. casei; Carnobacterium divergence (Carnobacterium
divergens), lactic acid bacteria of the genus Carnobacterium such as Carnobacterium piscicola; Leuconostoc (Leuconostoc)
mesenteroides), lactic acid bacteria of the genus Leuconostoc such as Leuconostoc citreum; Streptococcus faecalis (Streptococcus)
faecalis), Streptococcus pyogenes and other Streptococcus lactic acid bacteria; Enterococcus caseliflavus, Enterococcus sulfreus and other Enterococcus sulfreus enterococcus (
Enterococcus) lactic acid bacteria; Lactococcus plantarum (Lactococcus)
lactic acid bacteria of the genus Lactococcus such as Lactococcus rafinolactis; Weissella confusa, lactic acid bacteria of the genus Weissella kandleri; Atopobium mintopum ) Lactic acid bacteria of the genus Atopobium; Vagococcus flubiaris (Vagococcus)
lactic acid bacteria of the genus Vagococcus such as fluvialis), Vagococcus salmoninarum; Pediococcus damnosus
damnosus), Pediococcus pentosaceus, and other lactic acid bacteria belonging to the genus Pediococcus. Among these lactic acid bacteria, the use of Lactobacillus plantarum is most preferable from the viewpoint of the skin physiological activity of the obtained fermented product and the ease of handling without being extremely anaerobic.
上記の乳酸菌を用いてハスの種子を発酵させる方法の好ましい具体例は以下の通りである。
まず、ハスの種子(以下「発酵素材」という)を溶媒に浸漬又は懸濁させて、発酵のための懸濁液を調製する。この場合、ハス種子は生のまま用いても、又予め乾燥もしくは半乾燥した上用いてもよい。又、形状としては、採取したものをそのまま用いることもできるが、細断又は粉砕して微細化すれば発酵効率を上げることができる。また、ハス種子の子実の最外層の渋皮は、発酵効率及び得られる発酵物の色相の点から、これを予め除去することが好ましく、又子実はそのまま用いるよりも、粉砕して粉末状として用いた方が、乳酸菌による栄養成分の利用がより行われ易くなって好ましい。
The preferable specific example of the method of fermenting a lotus seed using said lactic acid bacteria is as follows.
First, a lotus seed (hereinafter referred to as “fermentation material”) is immersed or suspended in a solvent to prepare a suspension for fermentation. In this case, the lotus seed may be used as it is, or may be used after previously dried or semi-dried. As the shape, the collected one can be used as it is, but if it is shredded or pulverized and refined, the fermentation efficiency can be increased. In addition, the outermost astringent skin of the seeds of lotus seed is preferably removed in advance from the viewpoint of fermentation efficiency and the hue of the resulting fermented product. It is preferable to use it because it is easier for the lactic acid bacteria to use the nutritional component.
発酵素材を懸濁させるための溶媒としては、水又は水と低級アルコール類(メタノール、エタノール、プロパノールなど)或いはグリコール類(エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、グリセリンなど)との混液等が用いられ、又それら溶媒中にはグルコース、フルクトース、シュークロースなどの糖類を添加してもよいが、乳酸菌が最もその作用を発揮しやすい点とハス種子の成分以外の資化成分の存在に基づく発酵副産物の生成を避けるという点から、水を単独で用いるのが最も好ましい。発酵素材と溶媒との混合比は、発酵素材の乾燥重量換算で一般に1:1〜1:1000、好ましくは1:5〜1:100、より好ましくは1:10〜1:50の範囲である。 As a solvent for suspending the fermentation material, water or a mixture of water and lower alcohols (methanol, ethanol, propanol, etc.) or glycols (ethylene glycol, propylene glycol, 1,3-butylene glycol, glycerin, etc.) In these solvents, sugars such as glucose, fructose and sucrose may be added. However, lactic acid bacteria are most likely to exert their action and there is an assimilation component other than the lotus seed component. From the standpoint of avoiding the formation of fermentation by-products based on the water, it is most preferred to use water alone. The mixing ratio of the fermentation material and the solvent is generally in the range of 1: 1 to 1: 1000, preferably 1: 5 to 1: 100, more preferably 1:10 to 1:50 in terms of dry weight of the fermentation material. .
この発酵素材/溶媒懸濁液は、これを発酵工程に供する前に、殺菌を行って発酵の障害となる雑菌を除去することが必要であるが、この雑菌の殺菌除去方法としては、発酵素材を予め殺菌用エタノール等で洗浄した後無菌水等の無菌溶媒に懸濁する方法を用いてもよく、又発酵素材を溶媒に懸濁した後、懸濁液を加熱殺菌等により殺菌するようにしてもよい。加熱殺菌処理としては、懸濁液を120〜130℃で10〜20分間加熱するオートクレーブ殺菌法や、80〜90℃に60〜120分間保持することを1日1回2〜3日間繰り返す間断殺菌法といった加熱殺菌法が一般に用いられる。 Before the fermentation material / solvent suspension is subjected to a fermentation process, it is necessary to sterilize and remove the germs that hinder the fermentation. May be used by washing with ethanol for sterilization in advance and then suspending in a sterile solvent such as sterile water. May be. As the heat sterilization treatment, the autoclave sterilization method in which the suspension is heated at 120 to 130 ° C. for 10 to 20 minutes, or holding at 80 to 90 ° C. for 60 to 120 minutes is repeated once a day for 2 to 3 days. The heat sterilization method such as the method is generally used.
次に、この無菌化した懸濁液を発酵タンクに入れ、これに乳酸菌を植菌して発酵を行う。乳酸菌の接種量は107〜108個/mLが適量である。接種量が上記の範囲より多くなっても発酵の進行時間は殆ど変わらず、一方上記の範囲より少なくなると発酵完了までに長時間を要することとなって好ましくない。 Next, this sterilized suspension is put into a fermentation tank, and lactic acid bacteria are inoculated therein for fermentation. The appropriate amount of lactic acid bacteria inoculated is 10 7 to 10 8 cells / mL. Even if the inoculation amount exceeds the above range, the fermentation progress time hardly changes. On the other hand, if the inoculation amount is less than the above range, it takes a long time to complete the fermentation.
発酵温度は一般に5〜50℃の範囲、好ましくは乳酸菌の生育至適温度である35℃〜40℃の範囲である。発酵日数は、至適温度に於いて一般に1〜10日、好ましくは2〜5日の範囲である。発酵日数が上記の一般的範囲より短くなると発酵が十分に行われず発酵物の有効性が低下する傾向にあり、一方10日を越えて長くしても有効性のそれ以上の上昇は認められないだけでなく、着色や発酵臭の増加が生ずることとなっていずれも好ましくない。 The fermentation temperature is generally in the range of 5 to 50 ° C, preferably in the range of 35 to 40 ° C, which is the optimum temperature for growth of lactic acid bacteria. The number of days of fermentation is generally in the range of 1 to 10 days, preferably 2 to 5 days, at the optimum temperature. If the fermentation days are shorter than the above general range, the fermentation is not sufficiently performed and the effectiveness of the fermented product tends to be reduced. On the other hand, if the fermentation days are longer than 10 days, no further increase in effectiveness is observed. Not only that, but also coloring and an increase in fermentation odor occur.
以上の発酵処理を行うに当たって、ハスの種子の成分が乳酸菌によってより有効に利用されるようにするため、乳酸菌の植菌前もしくは植菌と同時に、前記の懸濁液に酵素を添加して、ハスの種子に酵素による加水分解処理を施すことが好ましい。 In performing the above fermentation treatment, in order to more effectively use the lotus seed components by lactic acid bacteria, before or simultaneously with inoculation of lactic acid bacteria, an enzyme is added to the suspension, The lotus seed is preferably hydrolyzed with an enzyme.
この場合、酵素としては、蛋白分解酵素、澱粉分解酵素、ペクチン質分解酵素及び繊維素分解酵素から選ばれた少なくとも1種の酵素が用いられ、特にそれら4種の酵素群からそれぞれ選ばれた少なくとも1種の酵素を組み合わせ用いることによって好結果を得ることができる In this case, as the enzyme, at least one enzyme selected from a proteolytic enzyme, a starch degrading enzyme, a pectin degrading enzyme, and a fibrin degrading enzyme is used, and in particular, at least one selected from each of these four enzyme groups. Good results can be obtained by using one enzyme in combination.
ここで蛋白分解酵素としては、例えばアクチナーゼなどのアクチナーゼ類、ペプシンなどのペプシン類、トリプシン、キモトリプシンなどのトリプシン類、パパイン、キモパパインなどのパパイン類、グリシルグリシンペプチダーゼ、カルボキシペプチダーゼ、アミノペプチダーゼなどのペプチダーゼ類、ブロメラインなどを用いることができる。それら酵素のうちでも、アクチナーゼなどのアクチナーゼ類、パパイン、キモパパインなどのパパイン類又はブロメラインが特に好ましい。 Examples of proteolytic enzymes include actinases such as actinase, pepsins such as pepsin, trypsins such as trypsin and chymotrypsin, papains such as papain and chymopapain, peptidases such as glycylglycine peptidase, carboxypeptidase and aminopeptidase. And bromelain can be used. Among these enzymes, actinases such as actinase, papains such as papain and chymopapain, and bromelain are particularly preferable.
澱粉分解酵素としては、例えばα−アミラーゼ、β−アミラーゼ、グルコアミラーゼ、β−ガラクトシダーゼなどを用いることができる。それらの酵素のうちでも、グルコアミラーゼが特に好ましい。 As the starch degrading enzyme, for example, α-amylase, β-amylase, glucoamylase, β-galactosidase and the like can be used. Of these enzymes, glucoamylase is particularly preferred.
ペクチン質分解酵素としては、例えばペクチンデポリメラーゼ、ペクチンデメトキシラーゼ、ペクチンリアーゼ、ペクチンエステラーゼ、ポリガラクチュロナーゼなどを用いることができる。それらの酵素のうちでも、ペクチンエステラーゼとポリガラクチュロナーゼが特に好ましい。 Examples of pectin degrading enzymes that can be used include pectin depolymerase, pectin demethoxylase, pectin lyase, pectin esterase, and polygalacturonase. Of these enzymes, pectin esterase and polygalacturonase are particularly preferred.
繊維素分解酵素としては、例えばセルラーゼ、ヘミセルラーゼ、アガラーゼ、マンナーゼ、キチナーゼ、キトサナーゼ、カラゲナーゼ、アルギナーゼ、フコイダナーゼ、イヌラーゼ、キシラナーゼ、リグニナーゼなどを用いることができる。それらの酵素のうちでも、セルラーゼ、ヘミセルラーゼ及びリグニナーゼが特に好ましい。 Examples of the fibrinolytic enzyme include cellulase, hemicellulase, agarase, mannase, chitinase, chitosanase, carrageenase, arginase, fucoidanase, inulase, xylanase, and ligninase. Of these enzymes, cellulase, hemicellulase and ligninase are particularly preferred.
酵素の使用量は、懸濁液中のハスの種子の固形分に対して、合計で0.01〜10重量%が好ましく、より好ましくは0.1〜1.0重量%である。pH、温度、時間などの処理条件としては、酵素処理を発酵の前に行うのであれば、使用する酵素の至適pH及び至適温度付近で1〜24時間の処理を行うのがよく、一方発酵と同時に行うのであれば、当該発酵と同条件であって差し支えない。 The total amount of the enzyme used is preferably 0.01 to 10% by weight, more preferably 0.1 to 1.0% by weight, based on the solid content of the lotus seed in the suspension. As treatment conditions such as pH, temperature, and time, if the enzyme treatment is performed before fermentation, the treatment is preferably performed for 1 to 24 hours near the optimum pH and temperature of the enzyme used. If it is performed simultaneously with the fermentation, the same conditions as the fermentation may be used.
以上の発酵処理が終ったならば、殺菌のため、又酵素処理を併用した場合であれば酵素の失活も兼ねて、発酵物に70〜100℃で10〜120分程度の加熱殺菌処理を施した後、これをそのまま、或いは一般かつ好適にはろ過或いは遠心分離などの固液分離手段によって液相を分取し、必要ならばpHを通常の化粧料のpH領域であるpH6〜8に調整し、さらに必要ならば希釈もしくは濃縮によって適宜の濃度とした上、皮膚外用組成物の配合成分として供する。又、場合によっては、固液分離後の液相をスプレードライ法、凍結乾燥法など常法に従って粉末状とした上、皮膚外用組成物に配合してもよい。 When the above fermentation treatment is completed, the sterilization treatment is performed at 70 to 100 ° C. for about 10 to 120 minutes for the sterilization, and also when the enzyme treatment is used in combination, inactivation of the enzyme. After application, the liquid phase is separated as it is, or generally and preferably by solid-liquid separation means such as filtration or centrifugation, and if necessary, the pH is adjusted to pH 6-8, which is the pH range of ordinary cosmetics. It is adjusted and, if necessary, adjusted to an appropriate concentration by dilution or concentration, and then used as a blending component of the composition for external use on the skin. In some cases, the liquid phase after solid-liquid separation may be powdered according to a conventional method such as spray drying or freeze drying, and then blended into the composition for external use on the skin.
(d)ハトムギの種子の発酵物の調製
本発明で用いるハトムギは、イネ科ジュズダマ属の植物であって、薬用や食用に幅広く用いられているものである。本発明に於いては、ハトムギの種子の使用が好ましい。本発明において、ハトムギ種子は、殻付きのもの及び殻を除いたもののいずれもが使用可能であり、さらに粒のままでも、粉砕又は破砕して得た粉末、或いはハトムギ種子の粒、粉末の高温・高圧処理物等のいずれであってもよく、いずれの場合も同等でかつ元のハトムギ種子よりも強い皮膚生理活性を有する発酵物が得られるが、原料としての保存安定性や抽出・発酵効率の観点から、殻付き及び殻除去物のいずれの場合も、粉砕又は破砕して得た粉末、又はその高温・高圧処理物を用いることが好ましい。
(D) Preparation of pearl seed fermented pearl barley used in the present invention is a plant belonging to the genus Giusedama, and is widely used for medicinal purposes and food. In the present invention, the use of pearl barley seeds is preferred. In the present invention, pearl seeds can be used either with a shell or without a husk, and even in the form of grains, powder obtained by pulverization or crushing, or grains of pearl seed, high temperature of the powder Any high-pressure treated product can be used, and in any case, a fermented product that is equivalent and has stronger skin physiological activity than the original pearl seeds can be obtained, but storage stability and extraction / fermentation efficiency as raw materials From this point of view, it is preferable to use a powder obtained by pulverization or crushing, or a high-temperature / high-pressure processed product thereof, in both cases of shelled and shell-removed products.
本発明においては、ハトムギ種子の発酵に酵母を用いる。酵母として、例えば以下のものが挙げられる。
(1)サッカロミセス セレビシエ(Saccharomyces cerevisiae)、サッカロミセス
アワモリ(Saccharomyces awamori)、サッカロミセス チェバリエリ(Saccharomyces chevalieri)、サッカロミセス カールスバージェンシス(Saccharomyces carlsbergensis)、サッカロミセス バヨナス(Saccharomyces
bayonus)等のサッカロミセス属の酵母。
(2)トルラスポラ デルブルエキ(Torulaspora delbruekii)、トルラスポラ
ファーメンタチ(Torulaspora fermentati)、トルラスポラ ロゼイ(Torulaspora rosei)等のトルラスポラ属の酵母。
(3)ジゴサッカロミセス ローキシ(Zygosaccharomyces rouxii)、ジゴサッカロミセス
ソーヤ(Zygosaccharomyces soya)、ジゴサッカロミセス サケ(Zygosaccharomyces sake)、ジゴサッカロミセス ミソ(Zygosaccharomyces
miso)、ジゴサッカロミセス ラクティス(Zygosaccharomyces lactis)等のジゴサッカロミセス属の酵母。
(4)カンディダ ベルサチリス(Candida versatilis)、カンディダ エチェリシイ(Candida etchellsii)、カンディダ ケフィール(Candida
kefyr)、カンディダ サケ(Candida sake)、カンディダ スコッティ(Candida scottii)等のカンディダ属の酵母。
本発明においては、上記酵母のいずれも使用可能であるが、中でも食品に最も広く利用され、発酵力が強いといった点で、サッカロミセス・セレビシエ(Saccharomyces cerevisiae)が最も好ましい。
In the present invention, yeast is used for fermentation of pearl barley seeds. Examples of yeast include the following.
(1) Saccharomyces cerevisiae, Saccharomyces awamori, Saccharomyces chevalieri, Saccharomyces carlsbergensis, Saccharomyces carlsbergensis, Saccharomyces carlsbergensis
bayonus) and other yeasts of the genus Saccharomyces.
(2) Yeast of Torlaspora genus such as Torulaspora delbruekii, Torulaspora fermentati, Torulaspora rosei and the like.
(3) Zygosaccharomyces rouxii, Zygosaccharomyces soya, Zygosaccharomyces sake, Zygosaccharomyces sake, Zygosaccharomyces sake, Zygosaccharomyces sake
miso), yeast of the genus Digosaccharomyces such as Zygosaccharomyces lactis.
(4) Candida Versatilis (Candida versatilis), Candida Etchelisii (Candida etchellsii), Candida Kefir (Candida
kefyr), Candida sake, Candida scottii and other yeasts of the genus Candida.
In the present invention, any of the above yeasts can be used, but Saccharomyces cerevisiae is most preferred because it is most widely used for foods and has a strong fermenting power.
上記の酵母を用いてハトムギ種子を発酵させる方法の好ましい具体例は以下の通りである。
まず、ハトムギ種子又はハトムギ種子を粉砕もしくは破砕して得た粉末、或いはそれらの高温・高圧処理物を発酵媒体と混合して懸濁液を調製し、これに殺菌処理を施す。ここで発酵媒体としては、水、水とエタノール、プロパノールなどの低級アルコール類との混合液、水とエチレングリコール、プロピレングリコール、1,3−ブチレングリコールなどのグリコール類との混合液、水とソルビトール、グルコースなどの糖類との混合液等を用いることができるが、発酵に用いる酵母が最も作用し易いことと、ハトムギ種子に含まれる成分以外に酵母の栄養源となる成分を含まない点で、水単独の使用が最も好ましい。
The preferable specific example of the method of fermenting pearl seed using said yeast is as follows.
First, pearl seeds or powder obtained by pulverizing or pulverizing pearl seeds, or a high-temperature / high-pressure processed product thereof is mixed with a fermentation medium to prepare a suspension, which is sterilized. Here, as a fermentation medium, water, a mixed solution of water and lower alcohols such as ethanol and propanol, a mixed solution of water and glycols such as ethylene glycol, propylene glycol and 1,3-butylene glycol, water and sorbitol In addition, it is possible to use a mixed solution with sugars such as glucose, etc., but the yeast used for fermentation is most likely to act, and in addition to the components contained in pearl seeds, it does not contain components that serve as nutrients for yeast. Most preferred is the use of water alone.
ハトムギ種子と上記の発酵媒体との混合比は、重量比で一般に2:1〜1:1000の範囲であり、好ましくは1:2〜1:100、より好ましくは1:5〜1:50の範囲である。ハトムギ種子の量比が大き過ぎると液が粘性を持つため、ろ過操作等が困難となって収量が低下する傾向にあり、一方少な過ぎると、発酵物の固形分濃度、ひいては単位容積当たりの生理活性が低くなり、濃縮工程を余儀なく必要とする場合もあり、使い勝手の悪いものとなっていずれも好ましくない。 The mixing ratio of the pearl seed and the fermentation medium is generally in the range of 2: 1 to 1: 1000 by weight, preferably 1: 2 to 1: 100, more preferably 1: 5 to 1:50. It is a range. If the ratio of pearl seeds is too large, the liquid will have a viscosity, which tends to reduce the yield due to difficulties in filtration, etc. In some cases, the activity is low, and a concentration step is required, which makes the method unusable.
殺菌処理としては、ハトムギ種子懸濁液を120〜130℃で10〜20分間加熱するオートクレーブ殺菌法や、80〜90℃に60〜120分間保持することを1日1回2〜3日間繰り返す間断殺菌法といった加熱殺菌法が一般に用いられる。これに代えて、発酵素材のハトムギ種子それ自体を予め殺菌用エタノール等で洗浄殺菌しておき、これを無菌水等の無菌媒体に懸濁する方法を用いてもよく、また、懸濁液を調製した後に加熱殺菌しても良い。 As the sterilization treatment, an autoclave sterilization method in which pearl seed suspension is heated at 120 to 130 ° C. for 10 to 20 minutes, or holding at 80 to 90 ° C. for 60 to 120 minutes is repeated once a day for 2 to 3 days. A heat sterilization method such as a sterilization method is generally used. Alternatively, the fermented barley seed itself may be washed and sterilized with sterilizing ethanol in advance and suspended in a sterile medium such as sterile water. You may heat-sterilize after preparing.
次に、この無菌化したハトムギ種子懸濁液を発酵タンクに入れ、これに酵母を植菌して発酵を行う。酵母の接種量は107〜108個/mLが適量である。接種量が上記の範囲より多くなっても発酵の進行時間は殆ど変わらず、一方上記の範囲より少なくなると発酵完了迄に長時間を要することとなって好ましくない。 Next, this sterilized barley seed suspension is placed in a fermentation tank, and yeast is inoculated therein for fermentation. The appropriate amount of yeast inoculation is 10 7 to 10 8 cells / mL. Even if the inoculation amount is larger than the above range, the progress time of fermentation hardly changes. On the other hand, if the inoculation amount is smaller than the above range, it takes a long time to complete the fermentation, which is not preferable.
発酵温度は、5〜50℃の範囲であれば発酵が進行し目的の発酵物を得ることができるが、より好ましくは酵母の生育至適温度である30〜40℃の範囲である。発酵日数は、上記の至適温度で発酵を行う場合で一般に1〜10日であり、より好ましくは2〜5日である。発酵日数が1日より短いと発酵が十分に行われず、目的とする高い皮膚生理活性を有する発酵物を得ることが困難となる。一方、発酵日数が10日を越えて長くなり過ぎても、それ以上発酵は進行せず発酵物の有効性に向上が認められないだけでなく、かえって着色や発酵臭が強まるなどの不都合が生じ好ましくない。 If fermentation temperature is the range of 5-50 degreeC, fermentation will advance and the target fermented material can be obtained, More preferably, it is the range of 30-40 degreeC which is the optimal growth temperature of yeast. The number of fermentation days is generally 1 to 10 days, more preferably 2 to 5 days in the case of performing fermentation at the optimum temperature. When the fermentation days are shorter than one day, the fermentation is not sufficiently performed, and it becomes difficult to obtain a desired fermented product having high skin physiological activity. On the other hand, if the fermentation period is longer than 10 days, the fermentation does not proceed any further and the effectiveness of the fermented product is not improved, but inconveniences such as increased coloring and fermentation odor occur. It is not preferable.
所定の発酵日数が経過したならば、後述の酵素分解処理を発酵と併せ行った場合であれば当該酵素の失活を兼ねて、発酵物を例えば80〜90℃で60〜120分間加熱する方法などを用いて殺菌し、発酵を停止させた後、ろ過又は遠心分離などの固液分離手段を用いて不溶物を除去し、目的の発酵物を含む溶液を得る。ここに得られる発酵物溶液は、一般にはpHを4〜8に調整した上、これをそのまま化粧料に配合するか、もしくは必要ならば減圧濃縮等により所定の濃度に調整した上、皮膚外用組成物に配合する。又場合によっては、スプレードライ法、凍結乾燥法など常法に従って粉末化してもよい。 If the predetermined fermentation days have passed, if the enzyme decomposition treatment described below is performed together with fermentation, the fermentation product is heated at 80 to 90 ° C. for 60 to 120 minutes, for example, also for inactivation of the enzyme. After sterilizing using, etc. and stopping fermentation, insoluble matter is removed using solid-liquid separation means such as filtration or centrifugation to obtain a solution containing the desired fermentation product. The fermented product solution obtained here is generally adjusted to a pH of 4 to 8 and then directly blended into cosmetics or, if necessary, adjusted to a predetermined concentration by vacuum concentration, etc. Blend into the product. In some cases, the powder may be pulverized according to a conventional method such as spray drying or freeze drying.
なお、以上の発酵処理を行うに際して、発酵前及び/又は発酵と並行して、ハトムギ種子懸濁液に酵素による加水分解処理を施すようにしてもよく、これによってハトムギ種子の成分がより有効に酵母によって利用され発酵効率が上がるだけでなく、発酵物の流動特性や保存安定性も一段と良好なものとなることから好ましい。 In addition, when performing the above fermentation treatment, it may be possible to subject the pearl seed suspension to a hydrolysis treatment with an enzyme before fermentation and / or in parallel with the fermentation, thereby making the pearl seed components more effective. This is preferable because not only the fermentation efficiency is increased by yeast, but also the flow characteristics and storage stability of the fermented product are further improved.
酵素加水分解処理を行う場合、酵素としては、蛋白分解酵素、糖質分解酵素の2種の酵素群のそれぞれから少なくとも1種以上の酵素を選び、それらを組み合わせ用いるようにするのが好ましい。 When performing an enzymatic hydrolysis treatment, it is preferable to select at least one enzyme from each of two types of enzymes, a proteolytic enzyme and a saccharide-degrading enzyme, and use them in combination.
ここで蛋白分解酵素としては、例えばアクチナーゼなどのアクチナーゼ類、ペプシンなどのペプシン類、トリプシン、キモトリプシンなどのトリプシン類、パパイン、キモパパインなどのパパイン類、グリシルグリシンペプチダーゼ、カルボキシペプチダーゼ、アミノペプチダーゼなどのペプチダーゼ類、ブロメラインなどを用いることができる。
それら酵素のうちでも、アクチナーゼなどのアクチナーゼ類、パパイン、キモパパインなどのパパイン類或いはブロメラインが特に好ましい。
Examples of proteolytic enzymes include actinases such as actinase, pepsins such as pepsin, trypsins such as trypsin and chymotrypsin, papains such as papain and chymopapain, peptidases such as glycylglycine peptidase, carboxypeptidase, and aminopeptidase. And bromelain can be used.
Among these enzymes, actinases such as actinase, papains such as papain and chymopapain, and bromelain are particularly preferable.
糖質分解酵素としては、例えばα−アミラーゼ、β−アミラーゼ、グルコアミラーゼ、セルラーゼ、β−グルカナーゼ、β−キシラナーゼ、デキストラナーゼ、ポリガラクチュロナーゼ、α−ガラクトシダーゼ、β−ガラクトシダーゼ、プルラナーゼ、イソアミラーゼ、α−グルコシダーゼ、β−グルコシダーゼ、マルトトリオヒドロラーゼ、ペクチンデポリメラーゼ、ペクチンデメトキシラーゼ、ペクチンリアーゼ、ペクチンエステラーゼなどを用いることができる。それらの酵素のうちでも、グルコアミラーゼ、ペクチンエステラーゼとポリガラクチュロナーゼが特に好ましい。 Examples of the carbohydrase include α-amylase, β-amylase, glucoamylase, cellulase, β-glucanase, β-xylanase, dextranase, polygalacturonase, α-galactosidase, β-galactosidase, pullulanase, and isoamylase. , Α-glucosidase, β-glucosidase, maltotriohydrolase, pectin depolymerase, pectin demethoxylase, pectin lyase, pectin esterase and the like can be used. Of these enzymes, glucoamylase, pectinesterase and polygalacturonase are particularly preferred.
酵素の使用量は、ハトムギ種子懸濁液中の固形分に対して、合計量で0.01〜10重量%の範囲とするのがよく、より好ましくは0.1〜2.0重量%の範囲である。pH、温度、時間などの処理条件は、発酵と同条件であって差し支えないが、発酵前に酵素加水分解処理を行う場合には、用いる酵素の至適pH、至適温度付近で1〜24時間処理を行うようにすることが好ましい。 The amount of enzyme used should be in the range of 0.01 to 10% by weight, more preferably 0.1 to 2.0% by weight, based on the solid content in the pearl seed suspension. It is a range. The treatment conditions such as pH, temperature, and time may be the same as those for fermentation. However, when the enzyme hydrolysis treatment is performed before fermentation, the optimum pH of the enzyme to be used is 1 to 24 near the optimum temperature. It is preferable to perform time processing.
(e)シラン球根の抽出物の調製
本発明に用いるシランとは、ラン科シラン属の植物であるシラン[Bletilla striata(THUNB.)REICHB.fil]をいう。本発明においては、このシランの球根、即ち漢方生薬の白及(ビャッキュウ)の使用が好ましい。
(E) Preparation of Extract of Silane Bulb The silane used in the present invention refers to silane [Bletilla striata (THUNB.) REICHB.fil], which is a plant belonging to the genus Orchidaceae. In the present invention, it is preferable to use a bulb of silane, that is, a white herb of Chinese herbal medicine.
シラン球根の抽出物の調製は、この球根を、必要に応じて予め水洗、乾燥し、好ましくはさらに細切又は粉砕した上、浸漬法、向流抽出法など適宜の手段により抽出溶媒と接触させることによって行われる。 For the preparation of the silane bulb extract, the bulb is washed with water and dried in advance, if necessary, preferably further chopped or pulverized, and then contacted with an extraction solvent by an appropriate means such as a dipping method or a countercurrent extraction method. Is done by.
抽出溶媒としては、水;メタノール、エタノール、プロパノールなどの低級アルコール類、オレイルアルコール、ステアリルアルコール、オクチルドデカノールなどの高級アルコール類;エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、グリセリンなどの多価アルコール類;酢酸エチル、酢酸ブチル、プロピオン酸メチル、トリオクタン酸グリセリルなどのエステル類;アセトン、メチルエチルケトンなどのケトン類;エチルエーテル、イソプロピルエーテルなどのエーテル類;n−ヘキサン、トルエン、クロロホルムなどの炭化水素系溶媒などが挙げられ、それらは単独でもしくは二種以上混合して用いられる。それら抽出溶媒のうちでも、水、低級アルコール類及び多価アルコール類から選ばれた1種の単独溶媒又は2種以上の混合溶媒の使用が好ましく、なかでも水の単独使用が最も好ましい。 As an extraction solvent, water; lower alcohols such as methanol, ethanol, and propanol; higher alcohols such as oleyl alcohol, stearyl alcohol, and octyldodecanol; many solvents such as ethylene glycol, propylene glycol, 1,3-butylene glycol, and glycerin Monohydric alcohols; esters such as ethyl acetate, butyl acetate, methyl propionate and glyceryl trioctanoate; ketones such as acetone and methyl ethyl ketone; ethers such as ethyl ether and isopropyl ether; carbonization such as n-hexane, toluene and chloroform Examples thereof include hydrogen-based solvents, which are used alone or in combination of two or more. Among these extraction solvents, the use of one single solvent selected from water, lower alcohols and polyhydric alcohols, or two or more mixed solvents is preferable, and the single use of water is most preferable.
混合溶媒を用いる場合の混合比は、例えば水とエチルアルコールとの混合溶媒であれば、容量比(以下同じ)で1:1〜25:1、水とグリセリンとの混合溶媒であれば1:1〜15:1、又水と1,3−ブチレングリコールとの混合溶媒であれば、1:1〜15:1の範囲とすることが好ましい。 The mixing ratio in the case of using a mixed solvent is, for example, 1: 1 to 25: 1 by volume ratio (hereinafter the same) if the mixed solvent is water and ethyl alcohol, and 1: if the mixed solvent is water and glycerin. In the case of a mixed solvent of 1 to 15: 1 or water and 1,3-butylene glycol, it is preferably in the range of 1: 1 to 15: 1.
本発明の抽出物の調製に際して、抽出液のpHは5〜9の範囲に保持されることが好ましく、かかる意味で、必要ならば上記の抽出溶媒に、水酸化ナトリウム、炭酸ナトリウム、水酸化カリウムなどのアルカリ性調整剤や、クエン酸、塩酸、リン酸、硫酸などの酸性調整剤等を配合し、所望のpHとなるように調整してもよい。 In preparing the extract of the present invention, the pH of the extract is preferably maintained in the range of 5 to 9. In this sense, if necessary, the above extraction solvent may be sodium hydroxide, sodium carbonate, potassium hydroxide. An alkaline adjuster such as citric acid, hydrochloric acid, phosphoric acid, sulfuric acid or the like may be blended to adjust to a desired pH.
被抽出物に対する抽出溶媒の量比は、浸漬法の場合で一般に1:1〜1:50(重量比)の範囲、好ましくは1:5〜1:20の範囲である。 In the case of the immersion method, the amount ratio of the extraction solvent to the extract is generally in the range of 1: 1 to 1:50 (weight ratio), preferably in the range of 1: 5 to 1:20.
又、抽出温度、時間等の抽出条件は、用いる溶媒の種類、植物の抽出部位・細切度等によっても異なるが、例えば浸漬法の場合であれば、抽出温度は、一般に5〜100℃、好ましくは40〜90℃の範囲であり、又抽出時間は、0.5〜96時間程度、特に2〜24時間程度が好適である。 In addition, the extraction conditions such as extraction temperature and time vary depending on the type of solvent used, the extraction site / chopping degree of the plant, etc., but in the case of the immersion method, for example, the extraction temperature is generally 5 to 100 ° C., The temperature is preferably in the range of 40 to 90 ° C., and the extraction time is preferably about 0.5 to 96 hours, particularly about 2 to 24 hours.
ここに得られる抽出液は、一般にはpHを4〜8に調整した上、これをそのまま、もしくは希釈或いは減圧濃縮等により適宜の濃度に調整してもよく、又場合によっては、スプレードライ法、凍結乾燥法など常法に従って粉末化してもよい。 The extract obtained here may generally be adjusted to a pH of 4 to 8 and adjusted to an appropriate concentration as it is or by dilution or vacuum concentration. Powdering may be performed according to a conventional method such as freeze-drying.
本発明の皮膚外用組成物は、上記5つの植物由来成分を組み合わせて配合してなるものである。各成分の配合量は限定されるものではないが、例えば、好ましくは0.0001〜50重量%、より好ましくは、0.001〜30重量%、さらに好ましくは0.01〜10重量%である。 The external composition for skin of the present invention is a combination of the above five plant-derived components. Although the compounding quantity of each component is not limited, For example, Preferably it is 0.0001 to 50 weight%, More preferably, it is 0.001 to 30 weight%, More preferably, it is 0.01 to 10 weight%. .
また、本発明の皮膚外用組成物は、当該組成物の有効性を失わない範囲で、通常の皮膚外用剤に用いられる成分、例えば、例えば油性成分、界面活性剤(合成系、天然物系)、保湿剤、増粘剤、防腐・殺菌剤、粉体成分、紫外線吸収剤、抗酸化剤、美白剤、色素、香料等を必要に応じて適宜併用することができる。また、本発明の皮膚外用組成物の有効性、特長を損なわない限り、他の生理活性成分と組み合わせて皮膚外用剤に配合することも何ら差し支えない。 In addition, the composition for external use of the skin of the present invention is a component used for a normal external preparation for skin, for example, an oily component, a surfactant (synthetic system, natural product system) as long as the effectiveness of the composition is not lost. , Moisturizers, thickeners, antiseptics / bactericides, powder components, ultraviolet absorbers, antioxidants, whitening agents, pigments, fragrances and the like can be used in combination as needed. Moreover, as long as the effectiveness and characteristics of the external composition for skin of the present invention are not impaired, it may be combined with other physiologically active ingredients in the external preparation for skin.
ここで、油性成分としては、例えばオリーブ油、ホホバ油、ヒマシ油、大豆油、米油、米胚芽油、ヤシ油、パーム油、カカオ油、メドウフォーム油、シアーバター、ティーツリー油、アボガド油、マカデミアナッツ油、植物由来スクワランなどの植物由来の油脂類;ミンク油、タートル油などの動物由来の油脂類;ミツロウ、カルナウバロウ、ライスワックス、ラノリンなどのロウ類;流動パラフィン、ワセリン、パラフィンワックス、スクワランなどの炭化水素類;ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、イソステアリン酸、cis−11−エイコセン酸などの脂肪酸類;ラウリルアルコール、セタノール、ステアリルアルコールなどの高級アルコール類;ミリスチン酸イソプロピル、パルミチン酸イソプロピル、オレイン酸ブチル、2−エチルヘキシルグリセライド、高級脂肪酸オクチルドデシル(ステアリン酸オクチルドデシル等)などの合成エステル類及び合成トリグリセライド類等が挙げられる。 Here, as the oil component, for example, olive oil, jojoba oil, castor oil, soybean oil, rice oil, rice germ oil, palm oil, palm oil, cacao oil, meadow foam oil, sheer butter, tea tree oil, avocado oil, Oils derived from plants such as macadamia nut oil and plant-derived squalane; Fats derived from animals such as mink oil and turtle oil; waxes such as beeswax, carnauba wax, rice wax, lanolin; liquid paraffin, petrolatum, paraffin wax, squalane, etc. Hydrocarbons; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, cis-11-eicosenoic acid; higher alcohols such as lauryl alcohol, cetanol, stearyl alcohol; isopropyl myristate, palmitic acid Isopropyl, me Butyl phosphate, 2-ethylhexyl glycerides, higher fatty acid octyldodecyl (octyl stearate dodecyl and the like), and the synthetic esters and synthetic triglycerides such like.
界面活性剤としては、例えばポリオキシエチレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビトール脂肪酸エステルなどの非イオン界面活性剤;脂肪酸塩、アルキル硫酸塩、アルキルベンゼンスルホン酸塩、ポリオキシエチレンアルキルエーテル硫酸塩、ポリオキシエチレン脂肪アミン硫酸塩、ポリオキシエチレンアルキルフェニルエーテル硫酸塩、ポリオキシエチレンアルキルエーテル燐酸塩、α−スルホン化脂肪酸アルキルエステル塩、ポリオキシエチレンアルキルフェニルエーテル燐酸塩などのアニオン界面活性剤;第四級アンモニウム塩、第一級〜第三級脂肪アミン塩、トリアルキルベンジルアンモニウム塩、アルキルピリジニウム塩、2−アルキル−1−アルキル−1−ヒドロキシエチルイミダゾリニウム塩、N,N−ジアルキルモルフォルニウム塩、ポリエチレンポリアミン脂肪酸アミド塩などのカチオン界面活性剤;N,N−ジメチル−N−アルキル−N−カルボキシメチルアンモニオベタイン、N,N,N−トリアルキル−N−アルキレンアンモニオカルボキシベタイン、N−アシルアミドプロピル−N′,N′−ジメチル−N′−β−ヒドロキシプロピルアンモニオスルホベタインなどの両性界面活性剤等を使用することができる。
また、乳化剤乃至乳化助剤として、酵素処理ステビアなどのステビア誘導体、レシチン及びその誘導体、乳酸菌醗酵米、乳酸菌醗酵発芽米、乳酸菌醗酵穀類(麦類、豆類、雑穀など)等を配合することもできる。
Examples of the surfactant include polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene Nonionic surfactants such as oxyethylene sorbitol fatty acid esters; fatty acid salts, alkyl sulfates, alkylbenzene sulfonates, polyoxyethylene alkyl ether sulfates, polyoxyethylene fatty amine sulfates, polyoxyethylene alkyl phenyl ether sulfates, Polyoxyethylene alkyl ether phosphates, α-sulfonated fatty acid alkyl ester salts, polyoxyethylene alkyl phenyl ether phosphates, Quaternary ammonium salt, primary to tertiary fatty amine salt, trialkylbenzylammonium salt, alkylpyridinium salt, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salt, N N, N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine, N, N, N-trialkyl-N-, N, N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine Amphoteric surfactants such as alkylene ammoniocarboxybetaine and N-acylamidopropyl-N ′, N′-dimethyl-N′-β-hydroxypropylammoniosulfobetaine can be used.
In addition, stevia derivatives such as enzyme-treated stevia, lecithin and its derivatives, lactic acid bacteria fermented rice, lactic acid bacteria fermented germinated rice, lactic acid bacteria fermented cereals (eg wheat, legumes, millet), etc. .
保湿剤としては、例えばグリセリン、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコール、ソルビトール、キシリトール、ピロリドンカルボン酸ナトリウム等があり、さらにトレハロース等の糖類、乳酸菌醗酵米、ムコ多糖類(例えば、ヒアルロン酸及びその誘導体、コンドロイチン及びその誘導体、ヘパリン及びその誘導体など)、エラスチン及びその誘導体、コラーゲン及びその誘導体、NMF関連物質、乳酸、尿素、高級脂肪酸オクチルドデシル、海藻抽出物、魚介類由来コラーゲン及びその誘導体、各種アミノ酸及びそれらの誘導体が挙げられる。 Examples of humectants include glycerin, propylene glycol, dipropylene glycol, 1,3-butylene glycol, polyethylene glycol, sorbitol, xylitol, sodium pyrrolidonecarboxylate, and sugars such as trehalose, lactic acid bacteria fermented rice, and mucopolysaccharides. (For example, hyaluronic acid and its derivatives, chondroitin and its derivatives, heparin and its derivatives, etc.), elastin and its derivatives, collagen and its derivatives, NMF related substances, lactic acid, urea, higher fatty acid octyldodecyl, seaweed extract, seafood Examples include derived collagen and derivatives thereof, various amino acids and derivatives thereof.
増粘剤としては、例えばアルギン酸、寒天、カラギーナン、フコイダン等の褐藻、緑藻又は紅藻由来成分;ペクチン、ローカストビーンガム、アロエ多糖体等の多糖類;キサンタンガム、トラガントガム、グアーガム等のガム類;カルボキシメチルセルロース、ヒドロキシエチルセルロース等のセルロース誘導体;ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル酸・メタクリル酸共重合体等の合成高分子類;ヒアルロン酸及びその誘導体;ポリグルタミン酸及びその誘導体等が挙げられる。 Examples of the thickener include components derived from brown algae, green algae or red algae such as alginic acid, agar, carrageenan and fucoidan; polysaccharides such as pectin, locust bean gum and aloe polysaccharide; gums such as xanthan gum, tragacanth gum and guar gum; Cellulose derivatives such as methyl cellulose and hydroxyethyl cellulose; synthetic polymers such as polyvinyl alcohol, polyvinyl pyrrolidone, carboxyvinyl polymer, acrylic acid / methacrylic acid copolymer; hyaluronic acid and derivatives thereof; polyglutamic acid and derivatives thereof.
防腐・殺菌剤としては、例えば尿素;パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチルなどのパラオキシ安息香酸エステル類;フェノキシエタノール、ジクロロフェン、ヘキサクロロフェン、塩酸クロルヘキシジン、塩化ベンザルコニウム、サリチル酸、エタノール、ウンデシレン酸、フェノール類、ジャマール(イミダゾデイニールウレア)、1,2−ペンタンジオール、各種精油類、樹皮乾留物等がある。 Examples of the antiseptic / bactericidal agent include urea; paraoxybenzoates such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, and butyl paraoxybenzoate; phenoxyethanol, dichlorophene, hexachlorophene, chlorhexidine hydrochloride, benzaza chloride Luconium, salicylic acid, ethanol, undecylenic acid, phenols, jamal (imidazodenyl urea), 1,2-pentanediol, various essential oils, bark dry matter, and the like.
粉体成分としては、例えばセリサイト、酸化チタン、タルク、カオリン、ベントナイト、酸化亜鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコニウム、硫酸バリウム、無水ケイ酸、雲母、ナイロンパウダー、ポリエチレンパウダー、シルクパウダー、セルロース系パウダー、穀類(米、麦、トウモロコシ、キビなど)のパウダー、豆類(大豆、小豆など)のパウダー等がある。 Examples of powder components include sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, nylon powder, polyethylene powder, silk powder, and cellulose. System powders, powders of cereals (rice, wheat, corn, millet, etc.), powders of beans (soybeans, red beans, etc.).
紫外線吸収剤としては、例えばパラアミノ安息香酸エチル、パラジメチルアミノ安息香酸エチルヘキシル、サリチル酸アミル及びその誘導体、パラメトキシ桂皮酸2−エチルヘキシル、桂皮酸オクチル、オキシベンゾン、2,4−ジヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸塩、4−ターシャリーブチル−4−メトキシベンゾイルメタン、2−(2−ヒドロキシ−5−メチルフェニル)ベンゾトリアゾール、ウロカニン酸、ウロカニン酸エチル、アロエ抽出物等がある。 Examples of the ultraviolet absorber include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and derivatives thereof, 2-ethylhexyl paramethoxycinnamate, octyl cinnamate, oxybenzone, 2,4-dihydroxybenzophenone, 2-hydroxy-4 -Methoxybenzophenone-5-sulfonate, 4-tertiarybutyl-4-methoxybenzoylmethane, 2- (2-hydroxy-5-methylphenyl) benzotriazole, urocanic acid, ethyl urocanate, aloe extract, etc. .
抗酸化剤としては、例えばブチルヒドロキシアニソール、ブチルヒドロキシトルエン、没食子酸プロピル、ビタミンE及びその誘導体等がある。 Examples of the antioxidant include butylhydroxyanisole, butylhydroxytoluene, propyl gallate, vitamin E and derivatives thereof.
美白剤としては、t−シクロアミノ酸誘導体、コウジ酸及びその誘導体、アスコルビン酸及びその誘導体、ハイドロキノン又はその誘導体、エラグ酸及びその誘導体、ニコチン酸及びその誘導体、レゾルシノール誘導体、トラネキサム酸及びその誘導体、4−メトキシサリチル酸カリウム塩、マグノリグナン(5,5'−ジプロピル−ビフェニル−2,2’−ジオール)、4−HPB(ロドデノール、4−(4−ヒドロキシフェニル)−4−ブタノール))、ヒドロキシ安息香酸及びその誘導体、ビタミンE及びその誘導体、α−ヒドロキシ酸、AMP(アデノシンモノホスフェイト、アデノシン1リン酸)が挙げられ、これらを単独で配合しても、複数を組み合わせて配合しても良い。 Examples of whitening agents include t-cycloamino acid derivatives, kojic acid and derivatives thereof, ascorbic acid and derivatives thereof, hydroquinone or derivatives thereof, ellagic acid and derivatives thereof, nicotinic acid and derivatives thereof, resorcinol derivatives, tranexamic acid and derivatives thereof, 4 -Methoxysalicylic acid potassium salt, magnolignan (5,5'-dipropyl-biphenyl-2,2'-diol), 4-HPB (rhodenol, 4- (4-hydroxyphenyl) -4-butanol)), hydroxybenzoic acid And derivatives thereof, vitamin E and derivatives thereof, α-hydroxy acid, and AMP (adenosine monophosphate, adenosine monophosphate). These may be used alone or in combination.
上記のコウジ酸誘導体としては、例えばコウジ酸モノブチレート、コウジ酸モノカプレート、コウジ酸モノパルミテート、コウジ酸ジブチレートなどのコウジ酸エステル類、コウジ酸エーテル類、コウジ酸グルコシドなどのコウジ酸糖誘導体等が、アスコルビン酸誘導体としては、例えばL−アスコルビン酸−2−リン酸エステルナトリウム、L−アスコルビン酸−2−リン酸エステルマグネシウム、L−アスコルビン酸−2−硫酸エステルナトリウム、L−アスコルビン酸−2−硫酸エステルマグネシウムなどのアスコルビン酸エステル塩類、L−アスコルビン酸−2−グルコシド、L−アスコルビン酸−5−グルコシドなどのアスコルビン酸糖誘導体、それらアスコルビン酸糖誘導体の6位アシル化物(アシル基は、ヘキサノイル基、オクタノイル基、デカノイル基など)、L−アスコルビン酸テトライソパルミチン酸エステル、L−アスコルビン酸テトララウリン酸エステルなどのL−アスコルビン酸テトラ脂肪酸エステル類、3−O−エチルアスコルビン酸、L−アスコルビン酸−2−リン酸−6−O−パルミテートナトリウム、グリセルアスコルビン酸等が、ハイドロキノン誘導体としては、アルブチン(ハイドロキノン−β−D−グルコピラノシド)、α−アルブチン(ハイドロキノン−α−D−グルコピラノシド)等が、トラネキサム酸誘導体としては、トラネキサム酸エステル(例えば、トラネキサム酸ラウリルエステル、トラネキサム酸ヘキサデシルエステル、トラネキサム酸セチルエステル又はその塩)、トラネキサム酸のアミド体(例えば、トラネキサム酸メチルアミド)などが挙げられ、レゾルシノール誘導体としては、例えば、4−n−ブチルレゾルシノール、4−イソアミルレゾルシノール等が、2,5−ジヒドロキシ安息香酸誘導体としては、例えば2,5−ジアセトキシ安息香酸、2−アセトキシ−5−ヒドロキシ安息香酸、2−ヒドロキシ−5−プロピオニルオキシ安息香酸等が、ニコチン酸誘導体としては、例えばニコチン酸アミド、ニコチン酸ベンジル等が、ビタミンE誘導体としては、例えばビタミンEニコチネート、ビタミンEリノレート等が、α−ヒドロキシ酸としては、例えば乳酸、リンゴ酸、コハク酸、クエン酸、α−ヒドロキシオクタン酸等がある。 Examples of the kojic acid derivatives include kojic acid esters such as kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, kojic acid dibutyrate, kojic acid ethers, kojic acid sugar derivatives such as kojic acid glucoside, etc. However, as the ascorbic acid derivatives, for example, L-ascorbic acid-2-phosphate sodium, L-ascorbic acid-2-phosphate magnesium, L-ascorbic acid-2-sulfate sodium, L-ascorbic acid-2 -Ascorbic acid ester salts such as magnesium sulfate, L-ascorbic acid-2-glucoside, ascorbic acid sugar derivatives such as L-ascorbic acid-5-glucoside, 6-position acylated products of these ascorbic acid sugar derivatives (acyl group is Hexanoyl group, o L-ascorbic acid tetrafatty acid esters such as L-ascorbic acid tetraisopalmitate, L-ascorbic acid tetralaurate, 3-O-ethylascorbic acid, L-ascorbic acid- 2-phosphate-6-O-palmitate sodium, glycerascorbic acid and the like, and hydroquinone derivatives include arbutin (hydroquinone-β-D-glucopyranoside), α-arbutin (hydroquinone-α-D-glucopyranoside) and the like. Examples of the tranexamic acid derivative include tranexamic acid esters (for example, tranexamic acid lauryl ester, tranexamic acid hexadecyl ester, tranexamic acid cetyl ester or salts thereof), and amides of tranexamic acid (for example, tranexamic acid mesylate). Resorcinol derivatives include, for example, 4-n-butylresorcinol, 4-isoamylresorcinol and the like, and 2,5-dihydroxybenzoic acid derivatives include, for example, 2,5-diacetoxybenzoic acid, 2- Acetoxy-5-hydroxybenzoic acid, 2-hydroxy-5-propionyloxybenzoic acid and the like, nicotinic acid derivatives such as nicotinic acid amide and benzyl nicotinate, and vitamin E derivatives such as vitamin E nicotinate and vitamin Examples of α-hydroxy acids such as E-linoleate include lactic acid, malic acid, succinic acid, citric acid, and α-hydroxyoctanoic acid.
生理活性成分としては、胎盤抽出液、ソウハクヒ抽出物、ユキノシタ抽出物、米糠抽出物、米糠抽出物加水分解物、乳酸菌醗酵米、乳酸菌醗酵発芽米、乳酸菌醗酵穀類(麦類、豆類、雑穀類)、白芥子抽出物、ムラサキシキブ抽出物、ハス種子抽出物、党参抽出物、ハトムギ加水分解物、ローヤルゼリー発酵物、酒粕発酵物、パンダヌス・アマリリフォリウス(Pandanus amaryllifolius Roxb.)抽出物、アルカンジェリシア・フラバ(Arcangelicia flava Merrilli)抽出物、カミツレ抽出物、サンゴ草抽出物、ナス(水ナス、長ナス、賀茂ナス、米ナス等)抽出物、コンブ、カタメンキリンサイ等の海藻の抽出物、アマモ等の海産顕花植物の抽出物、リノール酸及びその誘導体もしくは加工物(例えばリポソーム化リノール酸など)、動物又は魚由来のコラーゲン及びその誘導体、エラスチン及びその誘導体、グリチルリチン酸及びその誘導体(ジカリウム塩等)、t−シクロアミノ酸誘導体、ビタミンA及びその誘導体、アラントイン、ジイソプロピルアミンジクロロアセテート、γ−アミノ−β−ヒドロキシ酪酸、ゲンチアナ抽出物、甘草抽出物、ニンジン抽出物、アロエ抽出物などの生薬抽出エキス、米醗酵エキス、ミツイシコンブ抽出物、アナアオサ抽出物、ジュアゼイロ(Zizyphus joazeiro)抽出物等がある。 Physiologically active ingredients include placenta extract, Sahakuhi extract, Yukinoshita extract, rice bran extract, rice bran extract hydrolyzate, lactic acid bacteria fermented rice, lactic acid bacteria fermented rice, lactic acid bacteria fermented cereal (wheat, legumes, millet) , White coconut extract, purple extract, lotus seed extract, party extract, pearl hydrolyzate, fermented royal jelly, fermented sake lees, Pandanus amaryllifolius Roxb. Flava (Arcangelicia flava Merrilli) extract, chamomile extract, coral grass extract, eggplant (water eggplant, long eggplant, Kamo eggplant, rice eggplant etc.) extract, seaweed extract such as kombu, catamen giraffe, sea bream, etc. Marine flowering plant extracts, linoleic acid and its derivatives or processed products (eg liposomal linoleic acid), animal or fish collagen And derivatives thereof, elastin and derivatives thereof, glycyrrhizic acid and derivatives thereof (dipotassium salts, etc.), t-cycloamino acid derivatives, vitamin A and derivatives thereof, allantoin, diisopropylamine dichloroacetate, γ-amino-β-hydroxybutyric acid, gentian extraction Herb extract, licorice extract, carrot extract, aloe extract, etc., rice fermentation extract, beetroot extract, anaosa extract, Zizyphus joazeiro extract and the like.
本発明の組成物を含む皮膚外用剤の適用部位としては、頭皮を含む皮膚全般が挙げられ、特に制限はない。従って、剤形としては、乳液、クリーム、ローション、エッセンス、軟膏、パック、ハップ剤、皮膚洗浄剤(石鹸類など)、洗顔料、シャンプー、リンス、トリートメント、各種メークアップ化粧料、浴剤など、多様なものとすることができる。また、本発明の皮膚外用組成物は、化粧品に限定されず、医薬部外品や医薬品にも用いることができる。 The application site of the external preparation for skin containing the composition of the present invention includes general skin including the scalp, and is not particularly limited. Therefore, the dosage forms include emulsions, creams, lotions, essences, ointments, packs, haps, skin cleansers (soaps, etc.), facial cleansers, shampoos, rinses, treatments, various makeup cosmetics, bath preparations, etc. It can be diverse. The composition for external use of the skin of the present invention is not limited to cosmetics, and can also be used for quasi drugs and pharmaceuticals.
次に、製造例、実施例、試験例及び処方例によって本発明をさらに具体的に説明するが、本発明はそれらに限定されるものではない。なお、以下において、部はすべて重量部を、また%はすべて重量%を意味する。 Next, the present invention will be described more specifically with reference to production examples, examples, test examples and formulation examples, but the present invention is not limited thereto. In the following, all parts are parts by weight, and all percentages are% by weight.
製造例1.米抽出物の加水分解物
精白米1000gに0.025mol/L水酸化ナトリウム溶液1250gを加え室温で、21時間攪拌した。ろ過によって固形物を除去し、抽出液をpH7.5に調製した。この抽出液にパパイン0.02%及びアクチナーゼ0.02%を加えて40℃で2時間加水分解を行った。酵素を加熱失活した後、この液をろ過して米抽出物加水分解液590gを得た(固形分濃度1.6%)。
Production Example 1 Hydrolyzate of rice extract 1250 g of 0.025 mol / L sodium hydroxide solution was added to 1000 g of polished white rice and stirred at room temperature for 21 hours. Solids were removed by filtration and the extract was adjusted to pH 7.5. Papain 0.02% and actinase 0.02% were added to this extract and hydrolyzed at 40 ° C. for 2 hours. After inactivating the enzyme by heating, this liquid was filtered to obtain 590 g of a rice extract hydrolyzed liquid (solid content concentration 1.6%).
製造例2.白芥子の酵素分解物
白芥の種子(白芥子)の粉砕物50gに精製水1000gを混合し、40℃で1時間抽出を行った後ろ過し、淡黄色透明の白芥子抽出物溶液820g(固形分濃度:1.2重量%)を得た。次に、ここに得られた抽出物溶液500gに、アクチナーゼAS(科研ファルマ株式会社製)を0.05g添加し、40℃で2時間加水分解した。その後、85℃で1時間加熱して酵素を失活させた後ろ過し、淡黄色透明の白芥子抽出物の加水分解物溶液450g(固形分濃度1.1重量%)を得た。
Production Example 2 Enzyme-decomposed product of white coconut 50 g of pulverized white birch seeds (white coconut) was mixed with 1000 g of purified water, extracted at 40 ° C. for 1 hour, filtered, and 820 g of a pale yellow transparent white coconut extract solution ( Solid concentration: 1.2% by weight) was obtained. Next, 0.05 g of actinase AS (manufactured by Kaken Pharma Co., Ltd.) was added to 500 g of the extract solution obtained here, and hydrolyzed at 40 ° C. for 2 hours. Thereafter, the enzyme was inactivated by heating at 85 ° C. for 1 hour, followed by filtration to obtain 450 g (solid content concentration 1.1% by weight) of a hydrolyzate solution of a pale yellow transparent white coconut extract.
製造例3.ハスの種子の発酵物
ハスの種子(渋皮を除去したもの)100gを粉砕し、精製水1900gを加えて懸濁液を調製し、加熱殺菌した。この懸濁液にグルコアミラーゼ1g、パパイン1g及びセルラーゼ0.5gを加えた後、乳酸菌(ラクトバチルス
プランタラム)を108個/mL接種し、窒素気流下に37℃で3日間静置培養した。培養終了後加熱殺菌し、培養液をろ過して、ハス種子の乳酸菌発酵物溶液1450g(固形分濃度2.7%)を得た。
Production Example 3 A lotus seed fermented lotus seed (with astringent skin removed) 100 g was crushed, 1900 g of purified water was added to prepare a suspension, and heat sterilized. After adding 1 g of glucoamylase, 1 g of papain and 0.5 g of cellulase to this suspension, 10 8 cells / mL of lactic acid bacteria (Lactobacillus plantarum) were inoculated, followed by static culture at 37 ° C. for 3 days under a nitrogen stream. . After completion of the culture, the mixture was sterilized by heating, and the culture solution was filtered to obtain 1450 g of a lotus seed fermented lactic acid bacterium solution (solid content concentration: 2.7%).
製造例4.ハトムギ種子の発酵物
殻を除いたハトムギ種子50gを粉砕し、精製水950gを加えて懸濁液を調製し、加熱殺菌をした。この懸濁液にグルコアミラーゼ0.5g、パパイン0.5gを加えた後、酵母(サッカロミセス セレビシエ)を107個/mL接種し、30℃で3日間静置培養した。培養終了後、加熱殺菌し、室温まで冷却後、ろ過してハトムギ種子発酵物溶液520gを得た(固形分濃度1.4%)。
Production Example 4 50 g of barley seeds excluding the fermented husk of barley seeds were pulverized, 950 g of purified water was added to prepare a suspension, and heat sterilized. After adding glucoamylase 0.5g and papain 0.5g to this suspension, 10 < 7 > / mL yeast (Saccharomyces cerevisiae) was inoculated, and it left still and culture | cultivated at 30 degreeC for 3 days. After completion of the culture, the mixture was sterilized by heating, cooled to room temperature, and filtered to obtain 520 g of a fermented pearl seed solution (solid concentration: 1.4%).
製造例5.シラン球根の抽出物
シラン球根の細切物100gに精製水900gを混合し、80℃で3時間抽出を行った後ろ過し、淡黄色透明の抽出物溶液510gを得た(固形分濃度2.3%)。
Production Example 5 Extract of Silane Bulb 100 g of chopped silane bulb was mixed with 900 g of purified water, extracted at 80 ° C. for 3 hours, and then filtered to obtain 510 g of a pale yellow transparent extract solution (solid content concentration 2. 3%).
以上の製造例により得られた酵素分解物、発酵物及び抽出物を混合して、本発明の皮膚外用組成物とする。例えば、下記表1のように、各成分を、組成物全量に対して、それぞれ溶液としての最終濃度が0.2%、又は1.0%となるように配合して、本発明の皮膚外用組成物とする。
[表1]
The composition for external use of the skin of the present invention is prepared by mixing the enzyme degradation product, fermented material and extract obtained in the above production examples. For example, as shown in Table 1 below, each component is blended so that the final concentration as a solution is 0.2% or 1.0% with respect to the total amount of the composition, and the external application of the skin of the present invention It is set as a composition.
[Table 1]
試験例1.表皮細胞賦活効果試験
実施例1,2に係る皮膚外用組成物の表皮細胞賦活効果を以下の方法により評価した。
[試験方法]
正常表皮角化細胞(NHEK(F))を4×103個/wellで96ウェルプレートに播種後、HuMedia-KG2培地(倉敷紡績(株))を用いて、37℃で24時間培養した。24時間培養後、実施例1,2の皮膚外用組成物を試料溶液として上記培地に添加し、さらに、48時間培養した。ここで、試料溶液は、製造例1,2の酵素分解物、製造例3,4の発酵物、及び製造例5の抽出物を、それぞれ上記培地の全量に対して溶液としての最終濃度がそれぞれ0.2%(すなわち、混合溶液として1.0%)となるように、又は1.0%(すなわち、混合溶液として5.0%)となるように添加した。培養終了後、細胞の呼吸活性(MTT活性)をMTT還元法(H.Tada et.al.,J.Immunol.Methods 93, 157, 1986)によって評価した。すなわち、ウェルプレートから培地を除去した後、0.03%のMTT試薬(3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazoliumbromide)を添加して37℃、1時間反応させ、生成したホルマザンをイソプロパノールで溶解させた後、570nmに於ける吸光度を測定し、細胞残渣による濁度(吸光度:630nm)を差し引いた値をMTT活性とした。なお、コントロールとして、上記試料溶液に代えてPBS(−)を培地に添加した場合のMTT活性も測定した。さらに、陽性対照として、上記試料溶液に代えて、100mMのグルコースを培地に添加した場合のMTT活性も測定した。本発明の実施例1,2に係る試料溶液のMTT活性は、コントロールのMTT活性値を100とした場合の相対値で表した。
Test Example 1 Epidermal cell activation effect test The epidermal cell activation effect of the composition for external use according to Examples 1 and 2 was evaluated by the following method.
[Test method]
Normal epidermal keratinocytes (NHEK (F)) were seeded in a 96-well plate at 4 × 10 3 cells / well, and then cultured at 37 ° C. for 24 hours using HuMedia-KG2 medium (Kurashikibo Co., Ltd.). After culturing for 24 hours, the compositions for external use in Examples 1 and 2 were added as sample solutions to the above medium, and further cultured for 48 hours. Here, the final concentration of the sample solution as a solution with respect to the total amount of the above-mentioned culture medium is the enzymatic degradation product of Production Examples 1 and 2, the fermentation product of Production Examples 3 and 4, and the extract of Production Example 5, respectively. It added so that it might become 0.2% (namely, 1.0% as a mixed solution), or 1.0% (namely, 5.0% as a mixed solution). After completion of the culture, the respiratory activity (MTT activity) of the cells was evaluated by the MTT reduction method (H. Tada et.al., J. Immunol. Methods 93, 157, 1986). That is, after removing the medium from the well plate, 0.03% MTT reagent (3- (4,5-dimethyl-2-thiazolyl) -2,5-diphenyl-2H-tetrazoliumbromide) was added, After reacting for 1 hour and dissolving the produced formazan with isopropanol, the absorbance at 570 nm was measured, and the value obtained by subtracting the turbidity (absorbance: 630 nm) due to the cell residue was defined as MTT activity. As a control, MTT activity was also measured when PBS (-) was added to the medium instead of the sample solution. Furthermore, as a positive control, MTT activity was measured when 100 mM glucose was added to the medium instead of the sample solution. The MTT activity of the sample solutions according to Examples 1 and 2 of the present invention was expressed as a relative value when the MTT activity value of the control was 100.
試験例1の結果を図1に示す。図1に示すように、本発明の実施例1,2に係る皮膚外用組成物は、濃度依存的に格段に優れた表皮細胞賦活効果を奏することが明らかになった。なお、陽性対照であるグルコースも同様に、表皮細胞賦活効果を示したことから、本試験系が正常に行われたことも明らかである。 The results of Test Example 1 are shown in FIG. As shown in FIG. 1, it became clear that the composition for external use of skin according to Examples 1 and 2 of the present invention has an excellent epidermal cell activation effect in a concentration-dependent manner. In addition, since glucose which is a positive control also showed an epidermal cell activation effect, it is clear that this test system was performed normally.
試験例2.プロスタグランジンE2(PGE2)生成抑制効果試験
実施例1,2に係る皮膚外用組成物の抗炎症効果をプロスタグランジンE2(以下「PGE2」という)生成抑制試験により、評価した。PGE2は、皮膚の炎症を惹起する炎症性のケミカルメディエーターであって、紫外線等の外的要因によりダメージを受けた皮膚細胞内で分泌される物質である。よって、このPGE2の生成抑制効果試験により、抗炎症効果を評価する。
[試験方法]
ウサギ角膜由来細胞(SIRC)を、10%FBS含有イーグル最少必須培地(日水製薬株式会社)に懸濁して96ウェルプレートに5×103個/wellとなるよう播種し、37℃で3日間培養した。3日間培養後、実施例1,2の皮膚外用組成物を試料溶液として上記培地に添加し、さらに、24時間培養した。ここで、試料溶液は、製造例1,2の酵素分解物、製造例3,4の発酵物、及び製造例5の抽出物を、それぞれ上記培地の全量に対して溶液としての最終濃度がそれぞれ0.2%(すなわち、混合溶液として1.0%)となるように、又は1.0%(すなわち、混合溶液として5.0%)となるように添加した。なお、上記試料溶液に代えてPBS(−)を添加した培地にて同様に上記細胞を24時間培養したものをコントロールとした。次に培養器の底面から100mJ/cm2の紫外線B波を照射し、さらに2日間培養後、培養上清に分泌されたPGE2の量を、PGE2測定キット(カイマンケイミカル社製)を用いて測定した。また、上記試料溶液に代えて陽性対照としてインドメタシン10μMを用いた場合のPGE2量も同様にして求めた。また、コントロールと同様にPBS(−)を添加し24時間培養後、紫外線を照射しない対照区も設けた。
Test Example 2 Prostaglandin E2 (PGE2) Production Suppression Effect Test The anti-inflammatory effect of the composition for external use according to Examples 1 and 2 was evaluated by a prostaglandin E2 (hereinafter referred to as “PGE2”) production inhibition test. PGE2 is an inflammatory chemical mediator that causes skin inflammation, and is a substance secreted in skin cells damaged by external factors such as ultraviolet rays. Therefore, the anti-inflammatory effect is evaluated by this PGE2 production inhibitory effect test.
[Test method]
Rabbit cornea-derived cells (SIRC) were suspended in 10% FBS-containing Eagle's minimum essential medium (Nissui Pharmaceutical Co., Ltd.), seeded in a 96-well plate at 5 × 10 3 cells / well, and incubated at 37 ° C. for 3 days. Cultured. After culturing for 3 days, the compositions for external use in Examples 1 and 2 were added as sample solutions to the above medium, and further cultured for 24 hours. Here, the final concentration of the sample solution as a solution with respect to the total amount of the above-mentioned culture medium is the enzymatic degradation product of Production Examples 1 and 2, the fermentation product of Production Examples 3 and 4, and the extract of Production Example 5, respectively. It added so that it might become 0.2% (namely, 1.0% as a mixed solution), or 1.0% (namely, 5.0% as a mixed solution). In addition, it was set as control which culture | cultivated the said cell similarly for 24 hours in the culture medium which added PBS (-) instead of the said sample solution. Next, an ultraviolet B wave of 100 mJ / cm 2 was irradiated from the bottom of the incubator, and after further culturing for 2 days, the amount of PGE 2 secreted into the culture supernatant was measured using a PGE 2 measurement kit (manufactured by Cayman Caymic). It was measured. In addition, the amount of PGE2 when indomethacin 10 μM was used as a positive control instead of the sample solution was determined in the same manner. Moreover, PBS (-) was added like control, and the control group which does not irradiate with an ultraviolet-ray after 24 hours culture | cultivation was also provided.
試験例2の結果を図2に示す。図2に示すように、本発明の実施例1,2に係る皮膚外用組成物は、濃度依存的に格段に優れたPGE2抑制効果を奏することが明らかになった。なお、陽性対照であるインドメタシンも同様にPGE2抑制効果を示したことから、本試験系が正常に行われたことも明らかである。 The results of Test Example 2 are shown in FIG. As shown in FIG. 2, it became clear that the composition for external use of skin according to Examples 1 and 2 of the present invention has a PGE2 suppressing effect that is remarkably excellent in a concentration-dependent manner. In addition, since indomethacin, which is a positive control, also showed a PGE2 inhibitory effect, it is clear that this test system was performed normally.
試験例3.メラニン生成抑制効果試験
実施例1,2に係る皮膚外用組成物のメラニン生成抑制効果を以下の方法により評価した。
[試験方法]
B16細胞(B16−F10)を6×104個を培養シャーレに播種後、10%FBS含有RPMI−1640培地(シグマアルドリッチ)を用いて24時間培養した。24時間培養後、実施例1,2の皮膚外用組成物を試料溶液として上記培地に添加し、さらに、B16細胞がコンフルエントになるまで培養した。ここで、試料溶液は、製造例1,2の酵素分解物、製造例3,4の発酵物、及び製造例5の抽出物を、それぞれ上記培地の全量に対して溶液としての最終濃度がそれぞれ0.2%(すなわち、混合溶液として1.0%)となるように、又は1.0%(すなわち、混合溶液として5.0%)となるように添加した。培養終了後、上記細胞をPBS(−)溶液で洗浄し、その後、0.5g/LのTrypsin/0.53mmol/L EDTA solution(ナカライテスク株式会社)を添加し、37℃で5分間静置することで、シャーレから細胞を剥離した細胞懸濁液を得た。細胞懸濁液を遠心分離(10000rpm、4℃)し、上清を除去後、10%
DMSO含有1N NaOH水溶液を加え、沸騰水浴中で5分間煮沸し、これを細胞溶解液とした。この細胞溶解液のメラニン量を吸光度(490nm)にて測定した。また、試料溶液の細胞に対する刺激性、増殖抑制などの影響を考慮して、細胞溶解液中のタンパク質量をBradford法にて測定し、タンパク質当たりのメラニン量を算出した。
なお、コントロールとして、上記試料溶液に代えてPBS(−)を培地に添加した場合のメラニン/タンパク量も測定した。さらに、陽性対照として、上記試料溶液に代えて、2mMのコウジ酸を培地に添加した場合のメラニン/タンパク量も測定した。なお、本発明の実施例1,2に係る試料溶液のメラニン生成抑制率を、コントロールのメラニン/タンパク量の値を100とした場合の相対値で表した。
Test Example 3 Melanin production inhibitory effect test The melanin production inhibitory effect of the compositions for external use according to Examples 1 and 2 was evaluated by the following method.
[Test method]
After seeding 6 × 10 4 B16 cells (B16-F10) in a culture dish, the cells were cultured for 24 hours using 10% FBS-containing RPMI-1640 medium (Sigma Aldrich). After culturing for 24 hours, the composition for external use of Examples 1 and 2 was added to the above medium as a sample solution, and further cultured until B16 cells became confluent. Here, the final concentration of the sample solution as a solution with respect to the total amount of the above-mentioned culture medium is the enzymatic degradation product of Production Examples 1 and 2, the fermentation product of Production Examples 3 and 4, and the extract of Production Example 5, respectively. It added so that it might become 0.2% (namely, 1.0% as a mixed solution), or 1.0% (namely, 5.0% as a mixed solution). After completion of the culture, the cells are washed with a PBS (−) solution, and then 0.5 g / L Trypsin / 0.53 mmol / L EDTA solution (Nacalai Tesque) is added and allowed to stand at 37 ° C. for 5 minutes. Thus, a cell suspension in which the cells were detached from the petri dish was obtained. The cell suspension is centrifuged (10000 rpm, 4 ° C.), and after removing the supernatant, 10%
DMSO-containing 1N NaOH aqueous solution was added, and the mixture was boiled in a boiling water bath for 5 minutes to obtain a cell lysate. The amount of melanin in this cell lysate was measured by absorbance (490 nm). In consideration of the effects of the sample solution on cell irritation and growth inhibition, the amount of protein in the cell lysate was measured by the Bradford method, and the amount of melanin per protein was calculated.
As a control, the amount of melanin / protein when PBS (-) was added to the medium instead of the sample solution was also measured. Further, as a positive control, the amount of melanin / protein when 2 mM kojic acid was added to the medium instead of the sample solution was also measured. In addition, the melanin production | generation suppression rate of the sample solution which concerns on Example 1, 2 of this invention was represented by the relative value when the value of melanin / protein amount of control is set to 100.
試験例3の結果を図3に示す。図3に示すように、本発明の実施例1,2に係る皮膚外用組成物は、濃度依存的に格段に優れたメラニン生成抑制効果を奏すことが明らかになった。なお、陽性対照であるコウジ酸も同様にメラニン生成抑制効果を示したことから、本試験系が正常に行われたことも明らかである。 The results of Test Example 3 are shown in FIG. As shown in FIG. 3, it became clear that the composition for external use of skin according to Examples 1 and 2 of the present invention has a remarkably excellent melanin production inhibitory effect in a concentration-dependent manner. In addition, since kojic acid which is a positive control also showed the melanin production inhibitory effect similarly, it is clear that this test system was performed normally.
以上のように、本発明に係る皮膚外用組成物は、表皮細胞賦活効果、PGE2生成抑制効果(抗炎症効果)、及びメラニン生成抑制効果を併せ持つことから、これらの作用機序に基づいて、様々な要因により生じる皮膚老化現象(シワ、タルミ、シミ、ソバカス等)を多面的かつ総合的に予防、改善することができる。 As described above, the external composition for skin according to the present invention has both an epidermal cell activation effect, a PGE2 production inhibitory effect (anti-inflammatory effect), and a melanin production inhibitory effect. The skin aging phenomenon (wrinkles, tarmi, stains, freckles, etc.) caused by various factors can be prevented and improved in a multifaceted and comprehensive manner.
<処方例1> 化粧水
下記表に示す配合割合で原料を配合し、常法に従って、化粧水を製造した。
(原料)
(重量%)
製造例1の酵素分解物 0.2
製造例2の酵素分解物 0.2
製造例3の発酵物 0.2
製造例4の発酵物 0.2
製造例5の抽出物 0.2
アスコルビン酸−2−グルコシド 2.0
ポリプロピレングリコール 2.0
オキシベンゾン 3.0
パラオキシ安息香酸エステル 0.5
クエン酸 適量
香料 適量
精製水 残部
合計 100.0
<Prescription Example 1> Lotion Toner lotion was formulated according to a conventional method by blending raw materials at the blending ratio shown in the following table.
(material)
(weight%)
Enzymatic degradation product of Production Example 1 0.2
Enzymatic degradation product of Production Example 2 0.2
Fermented product of Production Example 3 0.2
Fermented product of Production Example 4 0.2
Extract of Production Example 5 0.2
Ascorbic acid-2-glucoside 2.0
Polypropylene glycol 2.0
Oxybenzone 3.0
P-Hydroxybenzoate ester 0.5
Citric acid appropriate amount perfume appropriate amount purified water balance
Total 100.0
<処方例2> 化粧用クリーム
下記表に示す配合割合で原料を配合し、常法に従って、化粧用クリームを製造した。
(原料) (重量%)
製造例1の酵素分解物 1.0
製造例2の酵素分解物 1.0
製造例3の発酵物 1.0
製造例4の発酵物 1.0
製造例5の抽出物 1.0
アスコルビン酸−2−グルコシド 2.0
システイン 1.0
ステアリルアルコール 5.0
ステアリン酸 8.0
スクワラン 10.0
自己乳化型グリセリルモノステアレート 3.0
ポリオキシエチレンセチルエーテル(20E.0) 1.0
プロピレングリコール 5.0
水酸化カリウム 0.3
香料 適量
防腐剤 適量
精製水 残部
合計 100.0
<Prescription example 2> Cosmetic cream The raw materials were blended in the blending ratio shown in the following table, and a cosmetic cream was produced according to a conventional method.
(Raw material) (wt%)
Enzymatic degradation product of Production Example 1 1.0
Enzymatic degradation product of Production Example 2 1.0
Fermented product of Production Example 3 1.0
Fermented product of Production Example 4 1.0
Extract of Production Example 5 1.0
Ascorbic acid-2-glucoside 2.0
Cysteine 1.0
Stearyl alcohol 5.0
Stearic acid 8.0
Squalane 10.0
Self-emulsifying glyceryl monostearate 3.0
Polyoxyethylene cetyl ether (20E.0) 1.0
Propylene glycol 5.0
Potassium hydroxide 0.3
Perfume Appropriate amount Preservative Appropriate amount
Purified water balance
Total 100.0
Claims (1)
(a)米のアルカリ抽出物を2種以上の蛋白分解酵素で処理して得られた酵素分解物
(b)アブラナ科ブラシカ属の白芥(Brassica alba)の種子(白芥子)の抽出物を蛋白分解酵素で処理して得られる酵素分解物
(c)スイレン科(Nympaeaceae)ハス属(Nelumbo)の植物の種子を乳酸菌で発酵させて得られる発酵物
(d)ハトムギの種子を酵母で発酵させて得られる発酵物
(e)ラン科シラン属植物のシラン(Bletilla striata(THUNB.) REICHB.fil.)の球根の抽出物 An external composition for skin comprising the following (a) to (e) as essential components.
(A) Enzymatic degradation product obtained by treating alkaline extract of rice with two or more proteolytic enzymes (b) Extract of Brassica alba seeds (white coconut) of Brassicaceae Enzymatic degradation product obtained by treatment with proteolytic enzyme (c) Fermented product obtained by fermenting Nympaeaceae plant seeds with lactic acid bacteria (d) Fermenting pearl seeds with yeast (E) Bulb extract of silane (Bletilla striata (THUNB.) REICHB.fil.)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013012666A JP6462200B2 (en) | 2013-01-25 | 2013-01-25 | Skin external composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013012666A JP6462200B2 (en) | 2013-01-25 | 2013-01-25 | Skin external composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014144920A true JP2014144920A (en) | 2014-08-14 |
JP6462200B2 JP6462200B2 (en) | 2019-01-30 |
Family
ID=51425482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013012666A Active JP6462200B2 (en) | 2013-01-25 | 2013-01-25 | Skin external composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6462200B2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017105745A (en) * | 2015-12-02 | 2017-06-15 | 共栄化学工業株式会社 | Skin external preparation |
CN109498529A (en) * | 2017-09-15 | 2019-03-22 | 伽蓝(集团)股份有限公司 | The application of bletilla striata extract |
KR20200026147A (en) * | 2018-08-29 | 2020-03-10 | 주식회사 케미랜드 | Enzyme treated Krean red ginseng and Phaseolus rediatus. L., and method of making cream using thereof, and cosmetic composition comprising thereof |
CN112336672A (en) * | 2020-12-28 | 2021-02-09 | 中华全国供销合作总社南京野生植物综合利用研究所 | Fermentation method of bletilla striata fermentation product and application of bletilla striata fermentation product in whitening cosmetics |
CN114645070A (en) * | 2022-02-28 | 2022-06-21 | 北京焉支山科技有限公司 | Preparation method of hexose-6-phosphoric acid composition and application thereof in cosmetics |
CN115887341A (en) * | 2022-12-22 | 2023-04-04 | 广州雷诺生物科技有限公司 | Red rice enzymolysis extract and preparation method thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05221844A (en) * | 1992-02-17 | 1993-08-31 | Kyoei Kagaku Kogyo Kk | Aging-preventive cosmetic |
JPH0987133A (en) * | 1995-09-21 | 1997-03-31 | Techno-Bull:Kk | Cosmetic capable of preventing aging |
JPH09255526A (en) * | 1996-03-27 | 1997-09-30 | Shiseido Co Ltd | Cosmetic for preventing aging |
JP2005126394A (en) * | 2003-10-27 | 2005-05-19 | Kyoei Kagaku Kogyo Kk | Superoxide dismutase activity enhancer and cosmetic containing the same |
JP2005298489A (en) * | 2004-03-15 | 2005-10-27 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2005320308A (en) * | 2004-05-11 | 2005-11-17 | Kyoei Kagaku Kogyo Kk | Enzymic treated hydrolyzate and cosmetic comprising the same formulated therein |
JP2010138139A (en) * | 2008-12-15 | 2010-06-24 | Kyoei Kagaku Kogyo Kk | Skin-lightening agent and skin-lightening cosmetic |
JP2014105167A (en) * | 2012-11-26 | 2014-06-09 | Kyoei Kagaku Kogyo Kk | Cosmetic |
-
2013
- 2013-01-25 JP JP2013012666A patent/JP6462200B2/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05221844A (en) * | 1992-02-17 | 1993-08-31 | Kyoei Kagaku Kogyo Kk | Aging-preventive cosmetic |
JPH0987133A (en) * | 1995-09-21 | 1997-03-31 | Techno-Bull:Kk | Cosmetic capable of preventing aging |
JPH09255526A (en) * | 1996-03-27 | 1997-09-30 | Shiseido Co Ltd | Cosmetic for preventing aging |
JP2005126394A (en) * | 2003-10-27 | 2005-05-19 | Kyoei Kagaku Kogyo Kk | Superoxide dismutase activity enhancer and cosmetic containing the same |
JP2005298489A (en) * | 2004-03-15 | 2005-10-27 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2005320308A (en) * | 2004-05-11 | 2005-11-17 | Kyoei Kagaku Kogyo Kk | Enzymic treated hydrolyzate and cosmetic comprising the same formulated therein |
JP2010138139A (en) * | 2008-12-15 | 2010-06-24 | Kyoei Kagaku Kogyo Kk | Skin-lightening agent and skin-lightening cosmetic |
JP2014105167A (en) * | 2012-11-26 | 2014-06-09 | Kyoei Kagaku Kogyo Kk | Cosmetic |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017105745A (en) * | 2015-12-02 | 2017-06-15 | 共栄化学工業株式会社 | Skin external preparation |
CN109498529A (en) * | 2017-09-15 | 2019-03-22 | 伽蓝(集团)股份有限公司 | The application of bletilla striata extract |
KR20200026147A (en) * | 2018-08-29 | 2020-03-10 | 주식회사 케미랜드 | Enzyme treated Krean red ginseng and Phaseolus rediatus. L., and method of making cream using thereof, and cosmetic composition comprising thereof |
KR102286083B1 (en) * | 2018-08-29 | 2021-08-05 | 주식회사 케미랜드 | Enzyme treated Krean red ginseng and Phaseolus rediatus. L., and method of making cream using thereof, and cosmetic composition comprising thereof |
CN112336672A (en) * | 2020-12-28 | 2021-02-09 | 中华全国供销合作总社南京野生植物综合利用研究所 | Fermentation method of bletilla striata fermentation product and application of bletilla striata fermentation product in whitening cosmetics |
CN114645070A (en) * | 2022-02-28 | 2022-06-21 | 北京焉支山科技有限公司 | Preparation method of hexose-6-phosphoric acid composition and application thereof in cosmetics |
CN115887341A (en) * | 2022-12-22 | 2023-04-04 | 广州雷诺生物科技有限公司 | Red rice enzymolysis extract and preparation method thereof |
CN115887341B (en) * | 2022-12-22 | 2023-12-08 | 广州雷诺生物科技有限公司 | Red rice enzymolysis extract and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
JP6462200B2 (en) | 2019-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4563225B2 (en) | Cosmetics | |
JP5129440B2 (en) | Fermented plant and cosmetics containing the same | |
JP4693623B2 (en) | Cosmetics | |
JP4734093B2 (en) | Cosmetics | |
JP2018193341A (en) | Plant fermentation product | |
JP4927337B2 (en) | Cosmetics | |
JP6462200B2 (en) | Skin external composition | |
JP5147805B2 (en) | Cosmetics | |
JP6928429B2 (en) | Topical skin agent | |
JP2017039680A (en) | Skin external composition and oral composition | |
JP2019034899A (en) | External composition for skin | |
JP5780706B2 (en) | Whitening cosmetics | |
JP5054945B2 (en) | Cosmetics | |
JP6706017B2 (en) | Stem cell function maintenance agent | |
JP6474186B2 (en) | Cosmetics | |
JP4488861B2 (en) | Cosmetics | |
JP5773356B2 (en) | Cosmetics | |
JP5483928B2 (en) | Cosmetics | |
JP2011032186A (en) | Cosmetic | |
JP2018193336A (en) | Skin external preparation | |
JP5900915B2 (en) | Whitening cosmetics | |
JP2021024805A (en) | External preparation for skin | |
JP6951908B2 (en) | Topical skin agent | |
JP2010138139A (en) | Skin-lightening agent and skin-lightening cosmetic | |
JP5737896B2 (en) | Cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160121 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20161104 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161129 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170127 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20170328 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170628 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20170913 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20171102 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181227 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6462200 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |